<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">71931</article-id><article-id pub-id-type="doi">10.7554/eLife.71931</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>C-type natriuretic peptide facilitates autonomic Ca<sup>2+</sup> entry in growth plate chondrocytes for stimulating bone growth</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-245249"><name><surname>Miyazaki</surname><given-names>Yuu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-114688"><name><surname>Ichimura</surname><given-names>Atsuhiko</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0366-5211</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-245250"><name><surname>Kitayama</surname><given-names>Ryo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-245251"><name><surname>Okamoto</surname><given-names>Naoki</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-245252"><name><surname>Yasue</surname><given-names>Tomoki</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-245253"><name><surname>Liu</surname><given-names>Feng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-270099"><name><surname>Kawabe</surname><given-names>Takaaki</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-270100"><name><surname>Nagatomo</surname><given-names>Hiroki</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-245254"><name><surname>Ueda</surname><given-names>Yohei</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-245255"><name><surname>Yamauchi</surname><given-names>Ichiro</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-245256"><name><surname>Hakata</surname><given-names>Takuro</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-245257"><name><surname>Nakao</surname><given-names>Kazumasa</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-115848"><name><surname>Kakizawa</surname><given-names>Sho</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-115849"><name><surname>Nishi</surname><given-names>Miyuki</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-115850"><name><surname>Mori</surname><given-names>Yasuo</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-163292"><name><surname>Akiyama</surname><given-names>Haruhiko</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-245258"><name><surname>Nakao</surname><given-names>Kazuwa</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-245259"><name><surname>Takeshima</surname><given-names>Hiroshi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4525-3725</contrib-id><email>takeshima.hiroshi.8m@kyoto-u.ac.jp</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kpeqv85</institution-id><institution>Graduate School of Pharmaceutical Sciences, Kyoto University</institution></institution-wrap><addr-line><named-content content-type="city">Kyoto</named-content></addr-line><country>Japan</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kpeqv85</institution-id><institution>Graduate School of Medicine, Kyoto University</institution></institution-wrap><addr-line><named-content content-type="city">Kyoto</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kpeqv85</institution-id><institution>Graduate School of Engineering, Kyoto University</institution></institution-wrap><addr-line><named-content content-type="city">Kyoto</named-content></addr-line><country>Japan</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024exxj48</institution-id><institution>Graduate School of Medicine, Gifu University</institution></institution-wrap><addr-line><named-content content-type="city">Gifu</named-content></addr-line><country>Japan</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kpeqv85</institution-id><institution>Medical Innovation Center, Kyoto University</institution></institution-wrap><addr-line><named-content content-type="city">Kyoto</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Safadi</surname><given-names>Fayez</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04q9qf557</institution-id><institution>Northeast Ohio Medical University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>15</day><month>03</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e71931</elocation-id><history><date date-type="received" iso-8601-date="2021-07-05"><day>05</day><month>07</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-02-27"><day>27</day><month>02</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-09-17"><day>17</day><month>09</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.09.17.460760"/></event></pub-history><permissions><copyright-statement>© 2022, Miyazaki et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Miyazaki et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-71931-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-71931-figures-v1.pdf"/><abstract><p>The growth plates are cartilage tissues found at both ends of developing bones, and vital proliferation and differentiation of growth plate chondrocytes are primarily responsible for bone growth. C-type natriuretic peptide (CNP) stimulates bone growth by activating natriuretic peptide receptor 2 (NPR2) which is equipped with guanylate cyclase on the cytoplasmic side, but its signaling pathway is unclear in growth plate chondrocytes. We previously reported that transient receptor potential melastatin-like 7 (TRPM7) channels mediate intermissive Ca<sup>2+</sup> influx in growth plate chondrocytes, leading to activation of Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) for promoting bone growth. In this report, we provide evidence from experiments using mutant mice, indicating a functional link between CNP and TRPM7 channels. Our pharmacological data suggest that CNP-evoked NPR2 activation elevates cellular cGMP content and stimulates big-conductance Ca<sup>2+</sup>-dependent K<sup>+</sup> (BK) channels as a substrate for cGMP-dependent protein kinase (PKG). BK channel-induced hyperpolarization likely enhances the driving force of TRPM7-mediated Ca<sup>2+</sup> entry and seems to accordingly activate CaMKII. Indeed, ex vivo organ culture analysis indicates that CNP-facilitated bone growth is abolished by chondrocyte-specific <italic>Trpm7</italic> gene ablation. The defined CNP signaling pathway, the NPR2-PKG-BK channel–TRPM7 channel–CaMKII axis, likely pinpoints promising target proteins for developing new therapeutic treatments for divergent growth disorders.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>bone development</kwd><kwd>Ca<sup>2+</sup> influx</kwd><kwd>chondrogenesis</kwd><kwd>membrane potential</kwd><kwd>natriuretic peptide receptor 2</kwd><kwd>TRPM7 channel</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>21H02663</award-id><principal-award-recipient><name><surname>Takeshima</surname><given-names>Hiroshi</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>20H03802</award-id><principal-award-recipient><name><surname>Ichimura</surname><given-names>Atsuhiko</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>21K19565</award-id><principal-award-recipient><name><surname>Ichimura</surname><given-names>Atsuhiko</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>JP19am0101092j0003</award-id><principal-award-recipient><name><surname>Takeshima</surname><given-names>Hiroshi</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006680</institution-id><institution>Takeda Medical Research Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ichimura</surname><given-names>Atsuhiko</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007325</institution-id><institution>Kobayashi International Scholarship Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ichimura</surname><given-names>Atsuhiko</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008731</institution-id><institution>Nakatomi Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ichimura</surname><given-names>Atsuhiko</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009665</institution-id><institution>Vehicle Racing Commemorative Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Takeshima</surname><given-names>Hiroshi</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004632</institution-id><institution>Mother and Child Health Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ichimura</surname><given-names>Atsuhiko</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Membrane potential adjustment required for growth plate chondrocytic signal conversion from cGMP to Ca<sup>2+</sup> influx toward long bone outgrowth.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The development of skeletal long bones occurs through endochondral ossification processes, during which chondrocyte layers form the growth plates at both ends of bone rudiments, and then the expanded cartilage portions are gradually replaced by trabecular bones through the action of osteoclasts and osteoblasts (<xref ref-type="bibr" rid="bib2">Berendsen and Olsen, 2015</xref>). Therefore, bone size largely depends on the proliferation of growth plate chondrocytes during endochondral development. On the other hand, atrial (ANP), brain (BNP), and C-type (CNP) natriuretic peptides regulate diverse cellular functions by activating the receptor guanylate cyclases, NPR1 and NPR2 (<xref ref-type="bibr" rid="bib22">Nakao et al., 1996</xref>). Of the natriuretic peptides, CNP exclusively stimulates bone development by acting on growth plate chondrocytes expressing the CNP-specific receptor NPR2 (<xref ref-type="bibr" rid="bib22">Nakao et al., 1996</xref>; <xref ref-type="bibr" rid="bib32">Wit and Camacho-Hübner, 2011</xref>; <xref ref-type="bibr" rid="bib25">Peake et al., 2014</xref>). Indeed, loss- and gain-of-function mutations in the human <italic>NPR2</italic> gene cause acromesomelic dysplasia and skeletal overgrowth disorder, respectively (<xref ref-type="bibr" rid="bib30">Vasques et al., 2014</xref>; <xref ref-type="bibr" rid="bib33">Wit et al., 2016</xref>). Furthermore, translational studies have been probing the benefits of CNP treatments in various animal models with impaired skeletal growth, and a phase III clinical trial of CNP therapy has recently been completed and approved for treatment of achondroplasia patients primarily resulting from mutations in the <italic>FGFR3</italic> gene (<xref ref-type="bibr" rid="bib28">Savarirayan et al., 2020</xref>). It is thus likely that NPR2 guanylate cyclase controls chondrocytic cGMP content during growth plate development. Downstream of NPR2 activation, cGMP-dependent protein kinase (PKG) seems to phosphorylate target proteins to facilitate growth plate chondrogenesis (<xref ref-type="bibr" rid="bib25">Peake et al., 2014</xref>). Activated PKG is postulated to stimulate the biosynthesis of growth plate extracellular matrix by playing an inhibitory role in the mitogen-activated protein kinase Raf–MEK–ERK cascade (<xref ref-type="bibr" rid="bib13">Krejci et al., 2005</xref>). In parallel, glycogen synthase kinase 3β (GSK3β) is likely activated by PKG-mediated phosphorylation, leading to the hypertrophic maturation of growth plate chondrocytes (<xref ref-type="bibr" rid="bib12">Kawasaki et al., 2008</xref>). However, it is still unclear how CNP promotes bone growth at the molecular level, and it is important to further address CNP signaling cascade in growth plate chondrocytes.</p><p>In the transient receptor potential channel superfamily, the melastatin subfamily member 7 (TRPM7) forms a mono- and divalent cation-permeable channel in various cell types and participates in important cellular processes including cell growth and adhesion (<xref ref-type="bibr" rid="bib6">Fleig and Chubanov, 2014</xref>). We recently reported that growth plate chondrocytes generate autonomic intracellular Ca<sup>2+</sup> fluctuations, which are generated by the intermittent gating of TRPM7 channels, and also that TRPM7-mediated Ca<sup>2+</sup> entry activates Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII), facilitating endochondral bone growth (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>). Based on these observations, we explored the link between CNP signaling and TRPM7-mediated Ca<sup>2+</sup> entry through the experiments described in this report. Our data obtained clearly indicate that big-conductance Ca<sup>2+</sup>-dependent K<sup>+</sup> (BK) channels play a key role in the functional coupling between NPR2 and TRPM7 channels in growth plate chondrocytes.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>CNP facilitates spontaneous Ca<sup>2+</sup> fluctuations in growth plate chondrocytes</title><p>In the growth plates of developing bones, proliferating cartilage cells, designated as round and columnar chondrocytes, frequently exhibit weak increases and decreases in intracellular Ca<sup>2+</sup> concentration under resting conditions (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>). On the other hand, previous in vivo studies demonstrated that CNP application (&gt;1 μmol/kg) stimulates endochondral bone growth (<xref ref-type="bibr" rid="bib22">Nakao et al., 1996</xref>). In our Fura-2 imaging of round chondrocytes within femoral bone slices prepared from wild-type mice, CNP pretreatments (30–300 nM for 1 hr) dose-dependently facilitated spontaneous Ca<sup>2+</sup> fluctuations (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). In particular, fluctuation-positive cell ratio and fluctuation amplitude were remarkably elevated in response to the CNP treatments. In contrast, ANP treatments exerted no effects on Ca<sup>2+</sup> fluctuations in growth plate chondrocytes.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>C-type natriuretic peptide (CNP)-induced facilitation of Ca<sup>2+</sup> fluctuations in growth plate chondrocytes.</title><p>(<bold>A</bold>) Fura-2 imaging of round chondrocytes pretreated with or without natriuretic peptides. Femoral bone slices prepared from wild-type C57BL embryos were pretreated with or without CNP and atrial natriuretic peptide (ANP), and subjected to Ca<sup>2+</sup> imaging. Representative recording traces from three cells are shown in each pretreatment group (upper panels). The effects of CNP and ANP pretreatments on spontaneous Ca<sup>2+</sup> fluctuations are summarized (lower graphs). The fluctuation-positive cell ratio, fluctuation amplitude and frequency were statistically analyzed, and significant differences from the control vehicle pretreatment are marked with asterisks (*p &lt; 0.05 and **p &lt; 0.01 in one-way analysis of variance (ANOVA) and Dunnett’s test). The data are presented as the means ± standard error of the mean (SEM). with <italic>n</italic> values indicating the number of examined mice. (<bold>B</bold>) Fura-2 imaging of round chondrocytes prepared from chondrocyte-specific <italic>Npr2</italic>-knockout (<italic>Npr2</italic><sup>fl/fl</sup>, <italic>Col2a1-Cre</italic><sup>+/−</sup>) and control (<italic>Npr2</italic><sup>fl/fl</sup>, <italic>Col2a1-Cre</italic><sup>−/−</sup>) mice. The bone slices were pretreated with CNP, and then subjected to Ca<sup>2+</sup> imaging. Representative recording traces are shown (left panels) and the CNP-pretreated effects are summarized (right graphs); significant differences from the wild-type group are marked with asterisks (*p &lt; 0.05 in one-way ANOVA and Tukey’s test). The data are presented as the means ± SEM with <italic>n</italic> values indicating the number of examined mice.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig1">Figure 1B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig1-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Chondrocyte-specific <italic>Npr2 ablation</italic>.</title><p>(<bold>A</bold>) Organization of floxed and deleted <italic>Npr2</italic> alleles. The chondrocyte-specific <italic>Npr2</italic>-knockout (<italic>Npr2</italic><sup>fl/fl</sup>, <italic>Col2a1-Cre</italic><sup>+/−</sup>) mice were previously generated (<xref ref-type="bibr" rid="bib23">Nakao et al., 2015</xref>). In this study, genotyping primers were newly designed, and <italic>Npr2</italic> ablation was evaluated in growth plates. The genomic map shows PCR primers for detecting the mutated <italic>Npr2</italic> alleles and <italic>Npr2</italic> mRNA. (<bold>B</bold>) <italic>Npr2</italic> gene ablation in various tissues from the chondrocyte-specific <italic>Npr2</italic>-knockout mice. Genomic DNAs were prepared from tissues (Gp, humeral growth plate; Br, brain; Lu, lung; Hr, heart; Lv, liver; Ki, kidney) from the E17.5 chondrocyte-specific <italic>Npr2</italic>-knockout and control embryos, and subjected to PCR analysis to detect the floxed and deleted <italic>Npr2</italic> alleles; the <italic>Col2a1-Cre</italic> transgene was also examined. (<bold>C</bold>) Reduction of <italic>Npr2</italic> mRNA in mutant growth plates prepared from the chondrocyte-specific <italic>Npr2</italic>-knockout mice. Total RNAs were prepared from humeral growth plates from the E17.5 embryos, and subjected to reverse transcription PCR (RT-PCR) analysis for estimating <italic>Npr2</italic> mRNA content. 18S ribosomal RNA was examined as an internal control. The relative mRNA contents were estimated from cycle thresholds in RT-PCR reactions and are summarized in the bar graph. (<bold>D</bold>) Total RNAs were prepared from humeral growth plate sections of the chondrocyte-specific <italic>Npr2</italic>-knockout (<italic>Npr2</italic><sup>fl/fl</sup><italic>, Col2a1-Cre<sup>+/−</sup></italic>) and control (<italic>Npr2</italic><sup>fl/fl</sup><italic>, Col2a1-Cre</italic><sup>−/−</sup>) E17.5 embryos and subjected to quantitative RT-PCR analysis. The cycle threshold (Ct) was determined for each RT-PCR reaction for estimating relative mRNA content. The data represent means ± standard error of the mean (SEM), and the numbers of mice examined are shown in parentheses. A significant difference between the genotype is marked with an asterisk (**p &lt; 0.01 in <italic>t</italic>-test).</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-71931-fig1-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-71931-fig1-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig1-figsupp1-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata4"><label>Figure 1—figure supplement 1—source data 4.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig1-figsupp1-data4-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Gene expression analysis in wild-type growth plate chondrocytes.</title><p>Total RNAs were prepared from growth plate sections packed with round chondrocytes or enriched with columnar and hypertrophic chondrocytes, and subjected to RT-PCR analysis. The cycle threshold (Ct) was determined for each RT-PCR reaction for estimating relative mRNA content. The data represent the mean ± standard error of the mean (SEM), and the numbers of mice examined are shown in parentheses. Significant differences between the growth plate sections are marked with asterisks (*p &lt; 0.05 and **p &lt; 0.01 in <italic>t</italic>-test). n.d.: not detectable.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig1-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig1-figsupp2-v1.tif"/></fig></fig-group><p>In chondrocyte-specific <italic>Npr2</italic>-knockout mice (<italic>Npr2</italic><sup>fl/fl</sup>, <italic>Col2a1-Cre</italic><sup>+/−</sup>), Cre recombinase is expressed under the control of the collagen type 2α1 gene promoter and thus inactivates the floxed <italic>Npr2</italic> alleles in a chondrocyte-specific manner (<xref ref-type="bibr" rid="bib23">Nakao et al., 2015</xref>). Our RT-PCR analysis indicated that the floxed <italic>Npr2</italic> gene was largely inactivated in the growth plates prepared from the E17.5 mutant embryos, but such recombination events were not detected in other tissues examined (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B</xref>). Accordingly, <italic>Npr2</italic> mRNA contents in the mutant growth plates were reduced to less than 40% of controls (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>), despite the growth plate preparations contain not only chondrocytes but also perichondrium-resident cells including undifferentiated mesenchymal cells and immature chondroblasts. Further RT-PCR analysis detected similar expression of representative chondrogenic marker genes between chondrocyte-specific <italic>Npr2</italic>-knockout and control bones, suggesting that the <italic>Npr2</italic> deficiency does not affect fundamental chondrogenesis in growth plates (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). In contrast to the imaging observations in wild-type and control bone slices, CNP treatments failed to enhance Ca<sup>2+</sup> fluctuations in the mutant round chondrocytes prepared from the chondrocyte-specific <italic>Npr2</italic>-knockout mice (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Therefore, CNP seems to facilitate spontaneous Ca<sup>2+</sup> fluctuations downstream of NPR2 activation in growth plate chondrocytes.</p></sec><sec id="s2-2"><title>Activated PKG facilitates spontaneous Ca<sup>2+</sup> fluctuations</title><p>CNP binds to NPR2 to activate its intrinsic guanylate cyclase and thus stimulates PKG by elevating cellular cGMP contents (<xref ref-type="bibr" rid="bib22">Nakao et al., 1996</xref>). CNP also binds to NPR3 which acts as a decoy receptor for ligand clearance, but the <italic>Npr3</italic> gene seemed to be inactive in growth plate chondrocytes (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Next, we pharmacologically verified the contribution of PKG to CNP-facilitated Ca<sup>2+</sup> fluctuations. The cGMP analog 8-(4-chlorophenylthio)-cyclic GMP (8-pCPT-cGMP) is widely used as a PKG-selective activator, while KT5823 is a typical PKG inhibitor. In wild-type growth plate chondrocytes pretreated with 8-pCPT-cGMP (100 μM for 1 hr), spontaneous Ca<sup>2+</sup> fluctuations were remarkably facilitated (<xref ref-type="fig" rid="fig2">Figure 2A</xref>); both fluctuation-positive cell rate and fluctuation amplitude were highly increased. In contrast, the bath application of KT5823 (2 μM) clearly attenuated CNP-facilitated Ca<sup>2+</sup> fluctuations within a short time frame (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Therefore, PKG activation seems to be essential for CNP-facilitated Ca<sup>2+</sup> fluctuations in growth plate chondrocytes.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Contribution of cGMP-dependent protein kinase (PKG) to C-type natriuretic peptide (CNP)-facilitated Ca<sup>2+</sup> fluctuations.</title><p>(<bold>A</bold>) Facilitated Ca<sup>2+</sup> fluctuations in round chondrocytes pretreated with the PKG activator 8-pCPT-cGMP. Wild-type bone slices were pretreated with or without the cGMP analog, and then subjected to Ca<sup>2+</sup> imaging. Representative recording traces are shown (left panels), and the pharmacological effects are summarized (right graphs). Significant differences between control and 8-pCPT-cGMP pretreatments are marked with asterisks (**p &lt; 0.01 in <italic>t</italic>-test). The data are presented as the means ± standard error of the mean (SEM) with <italic>n</italic> values indicating the number of examined mice. (<bold>B</bold>) Attenuation of CNP-facilitated Ca<sup>2+</sup> fluctuations by the PKG inhibitor KT5823. Wild-type bone slices were pretreated with CNP, and then subjected to Ca<sup>2+</sup> imaging. Representative recording traces are shown (left panel), and KT5823-induced effects are summarized (right graphs). Significant KT5823-induced shifts are marked with asterisks (**p &lt; 0.01 in <italic>t</italic>-test). The data are presented as the means ± SEM with <italic>n</italic> values indicating the number of examined mice.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig2">Figure 2A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig2">Figure 2B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig2-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig2-v1.tif"/></fig></sec><sec id="s2-3"><title>Activated BK channels contribute to CNP-facilitated Ca<sup>2+</sup> fluctuations</title><p>Spontaneous Ca<sup>2+</sup> fluctuations are facilitated by activated BK channels in growth plate chondrocytes (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>). Previous studies have established a functional link between PKG and BK channels in several cell types including smooth muscle and endothelial cells; activated PKG enhances BK channel gating by directly phosphorylating the α subunit KCNMA1 protein (<xref ref-type="bibr" rid="bib5">Dong et al., 2008</xref>; <xref ref-type="bibr" rid="bib7">Fukao et al., 1999</xref>; <xref ref-type="bibr" rid="bib31">White et al., 2000</xref>). We thus examined whether altered BK channel activity is associated with CNP-facilitated Ca<sup>2+</sup> fluctuations. The BK channel inhibitor paxilline (10 μM) exerted no obvious effects on basal Ca<sup>2+</sup> fluctuations in nontreated chondrocytes. However, the same paxilline treatments remarkably inhibited CNP-facilitated Ca<sup>2+</sup> fluctuations (<xref ref-type="fig" rid="fig3">Figure 3A</xref>); both fluctuation-positive cell ratio and fluctuation amplitude were clearly decreased after paxilline application. On the other hand, the BK channel activator NS1619 (30 μM) stimulated basal Ca<sup>2+</sup> fluctuations in the growth plate chondrocytes prepared from control mice. The NS1619-induced effects were preserved in the mutant chondrocytes prepared from chondrocyte-specific <italic>Npr2</italic>-knockout mice (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Therefore, BK channel activation is likely involved in CNP-facilitated Ca<sup>2+</sup> fluctuations in growth plate chondrocytes.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Contribution of BK channels to C-type natriuretic peptide (CNP)-facilitated Ca<sup>2+</sup> fluctuations.</title><p>(<bold>A</bold>) Attenuation of CNP-facilitated Ca<sup>2+</sup> fluctuations by the BK channel inhibitor paxilline in round chondrocytes. Wild-type bone slices were pretreated with or without CNP, and then subjected to Ca<sup>2+</sup> imaging. Representative recording traces are shown (left panels), and paxilline-induced effects are summarized (right graphs). Significant paxilline-induced shifts are marked with asterisks (*p &lt; 0.05 and **p &lt; 0.01 in one-way analysis of variance (ANOVA) and Tukey’s test). The data are presented as the means ± standard error of the mean (SEM) with <italic>n</italic> values indicating the number of examined mice. (<bold>B</bold>) Ca<sup>2+</sup> fluctuations facilitated by the BK channel activator NS1619 in <italic>Npr2</italic>-deficient chondrocytes. Bone slices were prepared from the chondrocyte-specific <italic>Npr2</italic>-knockout and control embryos, and NS1619-induced effects were examined in Ca<sup>2+</sup> imaging. Representative recording traces are shown (left panels), and the effects of NS1619 are summarized (right graphs). Significant NS1619-induced shifts are marked with asterisks (**p &lt; 0.01 in one-way ANOVA and Tukey’s test). The data are presented as the means ± SEM with <italic>n</italic> values indicating the number of examined mice.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig3">Figure 3A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig3-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig3">Figure 3B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig3-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Effects of phospholipase C (PLC) inhibitor U73122 on C-type natriuretic peptide (CNP)-facilitated Ca<sup>2+</sup> fluctuations.</title><p>In Ca<sup>2+</sup> imaging, U73122 was bath applied to wild-type round chondrocytes pretreated with or without CNP. Representative recording traces are shown (left panels), and the effects of U73122 are summarized (right bar graphs). Data represent means ± standard error of the mean (SEM), and the numbers of cells and mice examined are shown in parentheses in the keys and graph bars, respectively. Significant differences between before and after the U73122 treatment are marked with asterisks (*p &lt; 0.05 and **p &lt; 0.01 in one-way analysis of variance [ANOVA] and Tukey’s test).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Store Ca<sup>2+</sup> release in C-type natriuretic peptide (CNP)-treated round chondrocytes.</title><p>(<bold>A</bold>) Store Ca<sup>2+</sup> release triggered by 1-oleoyl lysophosphatidic acid (LPA) in wild-type round chondrocytes pretreated with or without CNP. Representative recording traces are shown (left panels), and LPA-evoked Ca<sup>2+</sup> responses are summarized (right graphs). Data represent means ± standard error of the mean (SEM), and the numbers of cells and mice examined are shown in parentheses in the keys and graph bars, respectively. No significant differences were observed between CNP- and vehicle-pretreated groups (one-way analysis of variance [ANOVA] and Tukey’s test). (<bold>B</bold>) Ca<sup>2+</sup> leak responses evoked by the sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA) pump inhibitor thapsigargin (TG) in wild-type round chondrocytes pretreated with or without CNP. Representative recording traces are shown (left panels), and TG-evoked Ca<sup>2+</sup> responses are summarized (right bar graphs). Data represent means ± SEM, and the numbers of cells and mice examined are shown in parentheses in the keys and graph bars, respectively. No significant differences were observed between CNP- and vehicle-pretreated groups (<italic>t</italic>-test).</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig3-figsupp2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3s2sdata2"><label>Figure 3—figure supplement 2—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig3-figsupp2-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig3-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Phospholipase C seems unrelated to CNP-facilitated Ca<sup>2+</sup> fluctuations</title><p>Ca<sup>2+</sup> fluctuations are maintained by phosphatidylinositol (PI) turnover in growth plate chondrocytes (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>). Although it has been reported that activated PKG inhibits phospholipase C (PLC) in smooth muscle (<xref ref-type="bibr" rid="bib8">Guo et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Huang et al., 2007</xref>; <xref ref-type="bibr" rid="bib24">Nalli et al., 2014</xref>; <xref ref-type="bibr" rid="bib34">Xia et al., 2001</xref>), it might be possible that NPR2 activation enhances basal PLC activity to facilitate Ca<sup>2+</sup> fluctuations. The PLC inhibitor U73122 (10 μM) remarkably inhibited basal Ca<sup>2+</sup> fluctuations in nontreated chondrocytes: the fluctuation-positive cell ratio and fluctuation amplitude reduced less than half in response to U73122 application (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). U73122 was also effective for CNP-facilitated Ca<sup>2+</sup> fluctuations, but the inhibitory efficiency seemed relatively weak compared to those on basal fluctuations. Given the different inhibitory effects, it is rather unlikely that PLC activation accompanies CNP-facilitated Ca<sup>2+</sup> fluctuations.</p><p>PKG stimulates sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA) by phosphorylating the Ca<sup>2+</sup> pump regulatory peptide phospholamban (PLN) in smooth and cardiac muscle cells (<xref ref-type="bibr" rid="bib3">Bibli et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Raeymaekers et al., 1988</xref>; <xref ref-type="bibr" rid="bib15">Lalli et al., 1999</xref>), and activated Ca<sup>2+</sup> pumps generally elevate stored Ca<sup>2+</sup> contents and thus stimulate store Ca<sup>2+</sup> release. RT-PCR data suggested that the <italic>Pln</italic> gene and the <italic>Atp2a2</italic> gene encoding SERCA2 are weakly active in growth plate chondrocytes (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). To examine the effects of CNP treatments on Ca<sup>2+</sup> stores, we examined Ca<sup>2+</sup> responses to the activation of Gq-coupled lysophosphatidic acid (LPA) receptors (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>) and the Ca<sup>2+</sup> pump inhibitor thapsigargin (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>). CNP- and vehicle-pretreated chondrocytes exhibited similar LPA-induced Ca<sup>2+</sup> release and thapsigargin-induced Ca<sup>2+</sup> leak responses. Therefore, CNP treatments seem ineffective for store Ca<sup>2+</sup> pumps in growth plate chondrocytes. Moreover, the dose dependency of Ca<sup>2+</sup> release by LPA (1–10 μM) was not altered between CNP- and vehicle-pretreated chondrocytes, implying that CNP does not affect basal PLC activity.</p><p>Among diverse Ca<sup>2+</sup> handling-related proteins, PLC, PLN, and BK channels have been reported as PKG substrates, however, our observations suggested that both PLC and PLN receive no obvious functional regulation in CNP-treated chondrocytes. On the other hand, the paxilline treatments diminished CNP-facilitated Ca<sup>2+</sup> fluctuations down to nontreated basal levels (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), suggesting that activated BK channels predominantly contribute to CNP-facilitated Ca<sup>2+</sup> fluctuations in growth plate chondrocytes.</p></sec><sec id="s2-5"><title>CNP induces BK channel-mediated hyperpolarization</title><p>To confirm the contribution of activated BK channels to CNP-facilitated Ca<sup>2+</sup> fluctuations, we conducted confocal imaging using the voltage-dependent dye oxonol VI. In this imaging analysis, depolarization results in the accumulation of the dye into cells, in which the fractional fluorescence intensity, normalized to the maximum intensity monitored in the bath solution containing 100 mM KCl, is thus increased (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, left panel). The fractional intensity of CNP-pretreated cells was significantly lower than that of nontreated cells in a normal bath solution (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, middle graph), although both cells exhibited similar intensity shifts in high K<sup>+</sup> bath solutions. Based on the recording data, we prepared a calibration plot for the relationship between the fractional intensity and theoretical membrane potential (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, right panel). In the tentative linear correlation, resting potentials of −46.4 ± 0.2 and −43.6 ± 0.3 mV were estimated in CNP- and nontreated cells, respectively. The estimated potentials closely approximate the reported value from monitoring articular chondrocytes using sharp microelectrodes (<xref ref-type="bibr" rid="bib4">Clark et al., 2010</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>BK channel-mediated hyperpolarization induced by C-type natriuretic peptide (CNP).</title><p>(<bold>A</bold>) Oxonol VI imaging of round chondrocytes pretreated with or without CNP. Wild-type bone slices were pretreated with or without CNP, and then subjected to membrane potential imaging. During contiguous treatments with high-K<sup>+</sup> solutions, cellular fluorescence intensities were monitored and normalized to the maximum value in the 100 mM KCl-containing solution to yield the fractional intensity (left panel). The resting fractional intensities were quantified and statistically analyzed in CNP- and vehicle-pretreated cells (middle graph). For preparing the calibration plot (right panel), the data from 10 cells in bathing solutions containing 4 (normal solution), 20, 40, 60, and 100 mM KCl are summarized; red and black lines indicate the estimated resting membrane potentials of CNP- and vehicle-pretreated cells, respectively. (<bold>B</bold>) Effects of the BK channel inhibitor paxilline on resting membrane potential in round chondrocytes. Recording data from 10 cells pretreated with or without CNP were averaged (left panel), and the fractional intensities elevated by paxilline are summarized (right graph). (<bold>C</bold>) Effects of the BK channel activator NS1619 on membrane potential in round chondrocytes. Recording data from 10 cells pretreated with or without CNP were averaged (left panel), and the fractional intensities in normal, 20 mM KCl and NS1619-containing 20 mM KCl solutions are summarized (right graph). Significant differences between CNP- and vehicle-pretreated cells are indicated by asterisks in (<bold>A</bold>) (**p &lt; 0.01 in <italic>t</italic>-test) and in (<bold>C</bold>) (**p &lt; 0.01 in one-way analysis of variance [ANOVA] and Dunn’s test). The data are presented as the means ± standard error of the mean (SEM) with <italic>n</italic> values indicating the number of examined mice.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig4-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig4-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Related to <xref ref-type="fig" rid="fig4">Figure 4C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig4-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig4-v1.tif"/></fig><p>In pharmacological assessments, paxilline elevated fractional intensities to the same levels in CNP- and nontreated chondrocytes (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Moreover, NS1619 decreased fractional intensities to the same levels in both cells under 20 mM KCl bathing conditions, which enabled us to reliably evaluate the reducing intensity shifts (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). The oxonol VI imaging data suggested that CNP treatments induce BK channel-mediated hyperpolarization and thus facilitate spontaneous Ca<sup>2+</sup> fluctuations by enhancing Ca<sup>2+</sup>-driving forces in growth plate chondrocytes.</p></sec><sec id="s2-6"><title>CNP enhances TRPM7-mediated Ca<sup>2+</sup> entry and CaMKII activity</title><p>Spontaneous Ca<sup>2+</sup> fluctuations are predominantly attributed to the intermissive gating of cell-surface TRPM7 channels in growth plate chondrocytes (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>). For pharmacological characterization of TRPM7 channels, FTY720 is used as a typical inhibitor, while NNC550396 is an activator. As reasonably expected, bath application of FTY720 (10 μM) clearly diminished CNP-facilitated Ca<sup>2+</sup> fluctuations (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). On the other hand, NNC550396 (30 μM) remarkably facilitated Ca<sup>2+</sup> fluctuations in nontreated chondrocytes, and this facilitation was preserved in the mutant chondrocytes prepared from chondrocyte-specific <italic>Npr2</italic>-knockout mice (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Therefore, CNP treatments likely facilitate TRPM7-mediated Ca<sup>2+</sup> influx in growth plate chondrocytes.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Enhanced TRPM7-mediated Ca<sup>2+</sup> entry by C-type natriuretic peptide (CNP) treatments.</title><p>(<bold>A</bold>) Inhibition of CNP-facilitated Ca<sup>2+</sup> fluctuations by the TRPM7 inhibitor FTY720 in round chondrocytes. Wild-type bone slices were pretreated with CNP, and then subjected to Ca<sup>2+</sup> imaging. Representative recording traces are shown (left panel), and the effects of FTY720 are summarized (right graphs). Significant FTY720-induced shifts are marked with asterisks (**p &lt; 0.01 in <italic>t</italic>-test). The data are presented as the means ± standard error of the mean (SEM) with <italic>n</italic> values indicating the number of examined mice. (<bold>B</bold>) Ca<sup>2+</sup> fluctuations facilitated by the TRPM7 channel activator NNC550396 in <italic>Npr2</italic>-deficient round chondrocytes. Bone slices were prepared from the chondrocyte-specific <italic>Npr2</italic>-knockout and control embryos, and NNC550396-induced effects were examined in Ca<sup>2+</sup> imaging. Representative recording traces are shown (left panels) and the effects of NNC550396 on Ca<sup>2+</sup> fluctuations are summarized (right graphs). Significant NNC550396-induced shifts in each genotype are marked with asterisks (**p &lt; 0.01 in one-way analysis of variance [ANOVA] and Tukey’s test). The data are presented as the means ± SEM with <italic>n</italic> values indicating the number of examined mice.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig5">Figure 5A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig5-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig5">Figure 5B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig5-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig5-v1.tif"/></fig><p>TRPM7-mediated Ca<sup>2+</sup> entry activates CaMKII in growth plate chondrocytes toward bone outgrowth (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>), and cellular CaMKII activity can be estimated by immunochemically quantifying its autophosphorylated form. In immunocytochemical analysis, CNP-pretreated growth plate chondrocytes were more decorated with the antibody against phospho-CaMKII than nontreated control cells (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). This CNP-facilitated decoration was abolished by the cotreatment of the CaMKII inhibitor KN93 (30 μM). This observation was further confirmed by Western blot analysis; CNP treatments increased the phospho-CaMKII population without affecting total CaMKII content in the cell lysates prepared from growth plates (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Therefore, CaMKII is likely activated downstream of enhanced TRPM7-mediated Ca<sup>2+</sup> entry in CNP-treated growth plate chondrocytes.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>CaMKII activation in C-type natriuretic peptide (CNP)-treated round chondrocytes.</title><p>(<bold>A</bold>) Immunohistochemical staining against phospho-CaMKII (p-CaMKII) in round chondrocytes. Wild-type bone slices were pretreated with or without CNP and the CaMKII inhibitor KN93, and then subjected to immunostaining with antibody to p-CaMKII. DAPI (4′,6-diamidino-2-phenylindole) was used for nuclear staining. Lower panels show high-magnification views of white-dotted regions in upper panels (scale bars, 10 μm). (<bold>B</bold>) Immunoblot analysis of total CaMKII and p-CaMKII in growth plate cartilage. Growth plate lysates were prepared from wild-type bone slices pretreated with or without CNP, and subjected to immunoblot analysis with antibodies against total CaMKII and p-CaMKII (upper panel). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was also analyzed as a loading control. The immunoreactivities observed were densitometrically quantified and are summarized (lower graph). A significant difference between CNP- and vehicle pretreatments is marked with an asterisk (*p &lt; 0.05 in one-way analysis of variance [ANOVA] and Tukey’s test). The data are presented as the means ± standard error of the mean (SEM) with <italic>n</italic> values indicating the number of examined mice.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-71931-fig6-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig6-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig6-v1.tif"/></fig></sec><sec id="s2-7"><title>Pharmacologically activated BK channels facilitate bone outgrowth</title><p>Based on the present data from in vitro experiments, the novel CNP signaling route, represented as the NPR2-PKG-BK channel–TRPM7 channel–CaMKII axis, can be proposed in growth plate chondrocytes. We attempted to examine the proposed signaling axis in metatarsal bone culture, a widely used ex vivo model system for analyzing bone growth and endochondral ossification (<xref ref-type="bibr" rid="bib9">Houston et al., 2016</xref>). CNP treatments expanded columnar chondrocytic zones without affecting cell densities to extend cultured wild-type metatarsal bones (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). The extension seemed to be mainly caused by enlarged extracellular matrix area, although CNP significantly dilated columnar cell sizes. In chondrocyte-specific <italic>Trpm7</italic>-knockout mice (<italic>Trpm7</italic><sup>fl/fl</sup>, <italic>Col11a2</italic>-Cre<sup>+/−</sup>), Cre recombinase is expressed under the control of the collagen type XI gene enhancer and promoter, and thus inactivates the floxed <italic>Trpm7</italic> alleles in cartilage cells (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>). The bone rudiments prepared from control embryos (<italic>Trpm7</italic><sup>fl/fl</sup>, <italic>Col11a2-Cre</italic><sup>−/−</sup>) regularly elongated during ex vivo culture, and their outgrowth was significantly stimulated by the supplementation with CNP (30 nM) into the culture medium (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). The histological observation of the growth plate regions demonstrated that the CNP treatment extended the columnar chondrocyte zone. In contrast, the mutant rudiments prepared from the chondrocyte-specific <italic>Trpm7</italic>-knockout embryos were reduced in initial size and did not respond to the CNP supplementation (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Therefore, CNP-facilitated bone outgrowth seems to require TRPM7 channels expressed in growth plate chondrocytes.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Contribution of TRPM7 channel to C-type natriuretic peptide (CNP)-facilitated bone outgrowth.</title><p>Loss of CNP-facilitated outgrowth in <italic>Trpm7</italic>-deficient bones. Metatarsal rudiments isolated from control (<italic>Trpm7</italic><sup>fl/fl</sup>, <italic>Col11a2-Cre</italic><sup>−/−</sup>) embryos (<bold>A</bold>) and chondrocyte-specific <italic>Trpm7</italic>-knockout (<italic>Trpm7</italic><sup>fl/fl</sup>, <italic>Col11a2-Cre</italic><sup>+/−</sup>) embryos (<bold>B</bold>) were precultured in normal medium for 6 days, and then cultured in medium supplemented with or without CNP for 3 days. Representative images of cultured metatarsals are shown (upper left panels; scale bar, 0.3 mm), and longitudinal bone outgrowth during the CNP-supplemented period was statistically analyzed in each genotype group (upper right graphs). Growth plate images in longitudinal sections of 3-day cultured bones with or without CNP treatments are presented in lower left panels (scale bar, 0.3 mm), and their high-magnification views in the round (R), columnar (C), and hypertrophic (H) chondrocyte zones are shown in lower right panels (scale bar, 30 μm). MD, mid-diaphysis. Summary of graphical representations of zonal sizes containing round, columnar, and hypertrophic chondrocytes and number of cells in each zone is shown in lower right graphs. Significant CNP-supplemented effects are marked with asterisks (*p &lt; 0.05 in <italic>t</italic>-test). The data are presented as the means ± standard error of the mean (SEM) with <italic>n</italic> values indicating the number of examined mice.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig7">Figure 7A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig7-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig7">Figure 7B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig7-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Histological analysis of metatarsal bones treated with C-type natriuretic peptide (CNP).</title><p>Metatarsal bones isolated from wild-type embryos were precultured in normal medium for 6 days, and then cultured in medium supplemented with or without CNP (30 nM) for 3 days. Longitudinal sections of cultured bones on day 3 after the CNP treatment are shown in upper left panels (scale bar, 0.3 mm), and high-magnification views of the round (R), columnar (C), and hypertrophic (H) chondrocyte zones in upper right panels (scale bar, 30 μm). MD, mid-diaphysis. Longitudinal bone outgrowth during the CNP-supplemented period was statistically analyzed in each group to present in the lower left graph. Histological observations are summarized in the lower right graphs; the zonal sizes, cellular (Cell) and extracellular matrix (ECM) areas within the columnar cell zone, cell sizes, and cell numbers were statistically analyzed. Data represent means ± standard error of the mean (SEM), and the numbers of mice examined are shown in parentheses in the keys. Significant differences between the groups are marked with asterisks (*p &lt; 0.05, **p &lt; 0.01 in <italic>t</italic>-test).</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig7-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Proposed C-type natriuretic peptide (CNP)-evoked signaling in growth plate chondrocytes.</title><p>(<bold>A</bold>) The schematic diagram representing the NPR2-PKG-BK channel–TRPM7 channel–CaMKII axis proposed as an essential CNP signaling cascade in growth plate chondrocytes. Previous studies proposed that the RAF–MEK–ERK axis is also involved in growth plate CNP signaling (<xref ref-type="bibr" rid="bib13">Krejci et al., 2005</xref>). (<bold>B</bold>) The schematic diagram representing the nitric oxide (NO- and atrial natriuretic peptide) (ANP)/brain natriuretic peptide (BNP)-induced relaxation signaling in vascular smooth muscle.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig7-figsupp2-v1.tif"/></fig></fig-group><p>In our proposed signaling axis, activated BK channels exert an essential role by converting the chemical signal into the electrical signal. We finally examined the effect of the BK channel activator NS1619 on bone outgrowth (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). NS1619 supplementation (30 μM) significantly stimulated the outgrowth of wild-type bone rudiments. In contrast, under the same culture conditions, no stimulation was detected in the mutant rudiments from the chondrocyte-specific <italic>Trpm7</italic>-deficient embryos (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). The observations seem to support our conclusion that CNP activates BK channels and thus facilitates TRPM7-mediated Ca<sup>2+</sup> influx in growth plate chondrocytes for stimulating bone outgrowth.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Facilitated bone outgrowth by BK channel activator.</title><p>Stimulated bone outgrowth by the BK channel activator NS1619. Metatarsal rudiments isolated from wild-type (<bold>A</bold>) and the chondrocyte-specific <italic>Trpm7</italic>-knockout embryos (<bold>B</bold>) were precultured in normal medium for 5 days, and then cultured in medium supplemented with or without NS1619 for 4 days. Representative images of cultured metatarsals are shown (left panels; scale bar, 0.3 mm), and longitudinal bone outgrowth during the NS1619-supplemented period was statistically analyzed in each genotype group (right graphs). A significant NS1619-supplemented effect is marked with asterisks (*p &lt; 0.05 in <italic>t</italic>-test). The data are presented as the means ± standard error of the mean (SEM) with <italic>n</italic> values indicating the number of examined mice.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Related to <xref ref-type="fig" rid="fig8">Figure 8A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig8-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata2"><label>Figure 8—source data 2.</label><caption><title>Related to <xref ref-type="fig" rid="fig8">Figure 8B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71931-fig8-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-fig8-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We reported that in growth plate chondrocytes, PLC and BK channels maintain autonomic TRPM7-mediated Ca<sup>2+</sup> fluctuations, which potentiate chondrogenesis and bone growth by activating CaMKII (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>). Based on the present data, together with the previous reports, we proposed a new CNP signaling axis in growth plate chondrocytes (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2A</xref>). CNP-induced NPR2 activation elevates cellular cGMP content and thus activates PKG, leading to the phosphorylation of BK channels. The resulting BK channel activation induces cellular hyperpolarization to facilitate TRPM7-mediated Ca<sup>2+</sup> entry by enhancing the Ca<sup>2+</sup>-driving force, leading to CaMKII activation. Therefore, it is likely that CaMKII activity is physiologically regulated by BK channels as a key player of the CNP signaling cascade. In a recent genetic study, several patients carrying loss-of-function mutations in the <italic>KCNMA1</italic> gene encoding BK channel α subunit were characterized by a novel syndromic growth deficiency associated with severe developmental delay, cardiac malformation, bone dysplasia, and dysmorphic features (<xref ref-type="bibr" rid="bib17">Liang et al., 2019</xref>). In the <italic>KCNMA1</italic>-mutated disorder, CNP signaling likely fails to facilitate TRPM7-mediated Ca<sup>2+</sup> fluctuations in growth plate chondrocytes and resulting insufficient Ca<sup>2+</sup> entry may lead to systemic bone dysplasia associated with stunted growth plate cartilage. On the other hand, the origin of CNP may still be ambiguous in the signaling scheme. Transgenic mice overexpressing CNP in a chondrocyte-specific manner develop a prominent skeletal overgrowth phenotype, suggesting autocrine CNP signaling in developing bones (<xref ref-type="bibr" rid="bib38">Yasoda et al., 2004</xref>). However, several genechip data in public databases indicate that prepro-CNP mRNA is abundantly expressed in the placenta among embryonic tissues (e.g., see the records under accession number GSE28277 in NCBI database). Therefore, it may be important to further examine which cell type primarily produces CNP to facilitate bone growth during embryonic development.</p><p>In our proposed CNP-signaling cascade, CaMKII is finally activated by TRPM7-mediated Ca<sup>2+</sup> influx in both round and columnar chondrocytes. However, it is still unclear how activated CaMKII contributes to bone outgrowth. Our obeservations in cultured metatarsal bones suggest that CNP expanded the columnar chondrocyte zone by stimulating the cell growth and enlarging the extracellular matrix area toward bone extension (<xref ref-type="fig" rid="fig7">Figure 7</xref>). The observations are roughly consistent with the previous studies using cultured tibias treated with CNP (<xref ref-type="bibr" rid="bib37">Yasoda et al., 1998</xref>; <xref ref-type="bibr" rid="bib20">Miyazawa et al., 2002</xref>). Therefore, activated CaMKII by TRPM7-mediated Ca<sup>2+</sup> influx probably phosphorylates key proteins controlling cell growth and extracellular matrix production in columner chondrocytes.</p><p>From a physiological point of view, it is interesting to note that the proposed CNP signaling axis has clear overlap with the nitric oxide (NO) and ANP/BNP signaling cascades for vascular relaxation (<xref ref-type="bibr" rid="bib19">Martel et al., 2010</xref>; <xref ref-type="bibr" rid="bib40">Zois et al., 2014</xref>; <xref ref-type="bibr" rid="bib14">Kubacka et al., 2018</xref>). In blood vessels, NO is produced by endothelial cells in response to various stimuli including shear stress and acetylcholine, and activates soluble guanylate cyclase in neighboring vascular smooth muscle cells. ANP and BNP are released from the heart in response to pathological stresses, such as atrial distension and pressure overload, and are delivered to activate the receptor guanylate cyclase NPR1 in vascular muscle. In either case, the resulting cGMP elevation followed by PKG activation induces BK channel-mediated hyperpolarization and thus inhibits L-type Ca<sup>2+</sup> channel gating, leading to vascular dilation due to decreased Ca<sup>2+</sup> entry into vascular muscle. Therefore, activated BK channels inhibit the voltage-dependent Ca<sup>2+</sup> influx in vascular muscle cells regarded as excitable cells (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2B</xref>). In contrast, activated BK channels reversely stimulate TRPM7-mediated Ca<sup>2+</sup> entry in growth plate chondrocytes classified as nonexcitable cells, because the channel activity is voltage independently maintained by the intrinsic PI turnover rate.</p><p>CNP is an effective therapeutic reagent for achondroplasia and divergent short statures (<xref ref-type="bibr" rid="bib38">Yasoda et al., 2004</xref>; <xref ref-type="bibr" rid="bib29">Ueda et al., 2016</xref>; <xref ref-type="bibr" rid="bib35">Yamashita et al., 2020</xref>), and the phase III clinical trial of CNP therapy is completed successfully (<xref ref-type="bibr" rid="bib22">Nakao et al., 1996</xref>). The proteins contributing to the CNP signaling axis may be new pharmaceutical targets for developing medications; in addition to NPR2, BK, and TRPM7 channels are reasonably considered promising targets. Moreover, phosphodiesterase subtypes might be useful targets, although the subtypes responsible for cGMP hydrolysis remain to be identified in growth plate chondrocytes. Chemical compounds specifically targeting the signaling axis defined in this study would be useful drugs for not only clinical treatment of developmental disorders but also artificially modifying body sizes in farm and pet animals.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Mouse: C57BL/6J</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">Jax: 000664</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Trpm7</italic><sup>fl/fl</sup>, <italic>Col11a2-Cre</italic> mice</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Npr2</italic><sup>fl/fl</sup>, <italic>Col2a1-Cre</italic> mice</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib23">Nakao et al., 2015</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho-CaMKII (Thr 286) (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#12716; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2713889">AB_2713889</ext-link></td><td align="left" valign="bottom">IF (1:200)WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CaMKII (Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#EP1829Y; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_868641">AB_868641</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GAPDH (Rabbit polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat#G9545; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_796208">AB_796208</ext-link></td><td align="left" valign="bottom">WB (1:10,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG-HRP (Mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">Cat#sc-2357; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_628497">AB_628497</ext-link></td><td align="char" char="." valign="bottom">1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit Alexa Flour 488 (Goat polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat#A-11008; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_143165">AB_143165</ext-link></td><td align="char" char="." valign="bottom">1:50</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Npr1</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AACAAGGAGAACAGCAGCAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Npr1</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TATCAAATGCCTCAGCCTGGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Npr2</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGCCCCATCCCTGATGAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Npr2</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCTGGTACCCCCTTCCTGTA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Npr3</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGTATGGGGACTTCTCTGTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Npr3</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCTGGTCTCATCTAGTCTCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">FlFor</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GTAACCTGGGTAGACTAGTTGTTGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">DelFor</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGTTATTTTGTGAGATGACG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Rev</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATGGTGGAGGAGGTCTTTAATTCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Col2a1</italic>-Cre_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CGTTGTGAGTTGGATAGTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Col2a1</italic>-Cre_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CATTGCTGTCACTTGGTCGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Prkg1</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATGGACTTTTTGTGGGACTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Prkg1</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGTTTTCATTGGATCTGGGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Prkg2</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TTGCGGAAGAAAATGATGTCG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Prkg2</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GAATGGGGAGGTTGAGGAGAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnma</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AATGCACTTCGAGGAGGCTA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnma</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTCAGCCGGTAAATTCCAAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnmb1</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACAACTGTGCTGCCCCTCTA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnmb1</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CACTGTTGGTTTTGATCCCG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnmb2</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCAGGAGACACCAACACTTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnmb2</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGTTAGTTTCACCATAGCAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnmb3</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GTGGATGACGGGCTGGACTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnmb3</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCACTTGGGGTTGGTCCTGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnmb4</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTCCTGACCAACCCCAAGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnmb4</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TAAAATAGCAAGTGAATGGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnn1</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCAAAAATGCTGCTGCAAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnn1</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCGTTCACCTTCCCTTGTTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnn2</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GATCTGGCAAAGACCCAGAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnn2</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GAAGTCCCTTTGCTGCTGTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnn3</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACTTCAACACCCGATTCGTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnn3</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGAAAGGAACGTGATGGAGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnn4</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGCACCTCACAGACACACTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Kcnn4</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TTTCTCCGCCTTGTTGAACT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Plcb1</italic>_F</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Yamazaki et al., 2011</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCCAAGTTGCGTGAACTTCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Plcb1</italic>_R</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Yamazaki et al., 2011</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GTTGCCAAGCTGAAAACCTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Plcb2</italic>_F</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Yamazaki et al., 2011</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACATCCAGGAAGTGGTCCAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Plcb2</italic>_R</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Yamazaki et al., 2011</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CGCACCGACTCCTTTACTTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Plcb3</italic>_F</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Yamazaki et al., 2011</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CAGGCCAGCACAGAGACATA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Plcb3</italic>_R</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Yamazaki et al., 2011</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGGATGCTGGCAATCAAATC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Plcg1</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AACGCTTTGAGGACTGGAGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Plcg1</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTCCTCAATCTCTCGCAAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Plcg2</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AACCCCAACCCACACGAGTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Plcg2</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AATGTTTCACCTTGCCCCTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Trpm7</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATTGCTTAGTTTTGGTGTTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Trpm7</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GATTGTCGGGAGAGTGGAGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Camk2a</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CACCACCATTGAGGACGAAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Camk2a</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGTTCAAAGGCTGTCATTCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Camk2b_</italic>F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AAGCAGATGGAGTCAAGCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Camk2b</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGCTGTCGGAAGATTCCAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Camk2d</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GATAAACAACAAAGCCAACG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Camk2d</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GTAAGCCTCAAAGTCCCCAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Camk2g</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CAAGAACAGCAAGCCTATCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Camk2g</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCTCTGACTGACTGGTGCGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde2a</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATCTTTGACCACTTCTCTCG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde2a</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CATAACCCACTTCAGCCATC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde3a</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AACTATACCTGCTCGGACTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde3a</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TTCGTGCGGCTTTATGCTGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde3b</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATTCCAAAGCAGAGGTCATC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde3b</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GTTAGAGAGCCAGCAGACAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde5a</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GACCCTTGCGTTGCTCATTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde5a</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGATGGAGTGACAGTACAGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6a</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AACCCACCCGCTGACCACTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6a</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTCTTCCTTCTTGTTGACGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6b</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCCGGGCCTATCTAAACTGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6b</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGAAGACAATTTCCCGGCCAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6c</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TTGCTCAGGAAATGGTTATG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6c</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GAAACAGAACTCGTACAGGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6d</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCCAAGAAAATCCTCAAGTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6d</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACAAAGCCAAACTCGAAGAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6g</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AAGGGTGAGATTCGGTCAGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6g</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCATCCCCAAACCCTTGCAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6h</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGCAGACTCGACAGTTCAAGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde6h</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTCCAGATGGCTGAACGCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde10a</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CATCCGCAAAGCCATCATCG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pde10a</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCTCATCACCCTCAGCCCAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar1</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCTTGGTGCCTTTATTGTCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar1</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGTAGGAGTAGATGATGGGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar2</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGTGTGCTGGTATTGCTGAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar2</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TTTGATGGAGAGCCTGGCAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar3</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACTTTCCCTTCTACTACCTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar3</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GTCTTTCCACAGCAATAACC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar4</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCTCAGTGGTGGTATTTCAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar4</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CACAGAAGAACAAGAAACAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar5</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AACACGACTTCTACCAACAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar5</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AAGACCCAGAGAGCCAGAGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar6</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TACTTTGCCATTTCGGATTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Lpar6</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCACTTCCTCCCATCACTGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Atp2a1</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CAAAACAGGGACCCTCACCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Atp2a1</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCCAGTGATGGAGAACTCGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Atp2a2</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AAACCAGATGTCCGTGTGCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Atp2a2</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGATGGCACTTCACTGGCTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Atp2a3</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCTCGGTCATCTGCTCTGAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Atp2a3</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Liu et al., 2021</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CGTGGTACCCGAAATGGTGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pln</italic>_F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TACCTCACTCGCTCGGCTAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pln</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGACGGAGTGCTCGGCTTTA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Sox9</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGGAAGCTGGCAGACCAGTA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Sox9</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CGTTCTTCACCGACTTCCTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Sox5</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTCGCTGGAAAGCTATGACC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Sox5</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GATGGGGATCTGTGCTTGTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Sox6</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGATTGGGGAGTACAAGCAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Sox6</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CATCTGAGGTGATGGTGTGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Runx2</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCCGGGAATGATGAGAACTA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Runx2</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGACCGTCCACTGTCACTTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pthlh</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTCCCAACACCAAAAACCAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Pthlh</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCTTGCCTTTCTTCTTCTTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Acan</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCTCACCATCCCCTGCTACT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Acan</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACTTGATTCTTGGGGTGAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Col10a1</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CAAGCCAGGCTATGGAAGTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Col10a1</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGCTGGGCCAATATCTCCTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Col2a1</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CACACTGGTAAGTGGGGCAAGACCG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Col2a1</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGATTGTGTTGTTTCAGGGTTCGGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>18</italic> S_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGACAAATCGCTCCACCAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>18</italic> S_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTCAACACGGGAAACCTCAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Actb</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CATCCGTAAAGACCTCTATGCCAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Actb</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATGGAGCCACCGATCCACA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Gapdh</italic>_F</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGTGTCCGTCGTGGATCTGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Gapdh</italic>_R</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TTGCTGTTGAAGTCGCAGGAG</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">ANP (Human, 1–28)</td><td align="left" valign="bottom">Peptide Institute</td><td align="left" valign="bottom">Cat#4135</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">CNP-22 (Human)</td><td align="left" valign="bottom">Peptide Institute</td><td align="left" valign="bottom">Cat#4229</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Amersham ECL Prime Western Blotting Detection Reagent</td><td align="left" valign="bottom">Cytiva</td><td align="left" valign="bottom">Cat#RPN2232</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ISOGEN</td><td align="left" valign="bottom">NipponGene</td><td align="left" valign="bottom">Cat#319-90211</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ReverTra Ace qPCR RT Master Mix with gDNA Remover</td><td align="left" valign="bottom">TOYOBO</td><td align="left" valign="bottom">Cat#FSQ-301</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FTY720</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">SML0700; CAS: 162359-56-0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fura-2 AM</td><td align="left" valign="bottom">DOJINDO</td><td align="left" valign="bottom">F025; CAS: 108964-32-5</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Hyaluronidase from sheep testes</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">H2126; CAS: 37326-33-3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">KN93</td><td align="left" valign="bottom">WAKO</td><td align="char" char="ndash" valign="bottom">115-00641; CAS: 139298-40-1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">KT5823</td><td align="left" valign="bottom">Cayman Chemical</td><td align="char" char="." valign="bottom">10010965; CAS: 126643-37-6</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">NNC 550396 dihydrochloride</td><td align="left" valign="bottom">Tocris Bioscience</td><td align="char" char="." valign="bottom">2268; CAS: 357400-13-6</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">NS1619</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">N170; CAS: 153587-01-0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">1-Oleoyl lysophosphatidic acid</td><td align="left" valign="bottom">Cayman Chemical</td><td align="char" char="." valign="bottom">62215: CAS: 325465-93-8</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Oxonol VI</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="char" char="." valign="bottom">75926; CAS: 64724-75-0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Paxilline</td><td align="left" valign="bottom">Tocris Bioscience</td><td align="char" char="." valign="bottom">2006; CAS: 57186-25-1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="char" char="hyphen" valign="bottom">8-pCPT-cGMP</td><td align="left" valign="bottom">Biolog</td><td align="left" valign="bottom">C009; CAS: 51239-26-0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Thapsigargin</td><td align="left" valign="bottom">Nacalai Tesque</td><td align="char" char="ndash" valign="bottom">33637-31; CAS: 67526-95-8</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">U73122</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">U6756; CAS: 112648-68-7</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Adobe Ilustrator</td><td align="left" valign="bottom">Adobe Systems</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.adobe.com/products/illustrator.html">http://www.adobe.com/products/illustrator.html</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism v7</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Leica Application Suite X</td><td align="left" valign="bottom">Leica MIcrosystems</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.leica-microsystems.com/products/microscope-software/p/leica-las-x-ls/">https://www.leica-microsystems.com/products/microscope-software/p/leica-las-x-ls/</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Reagents, primers, and mice</title><p>Reagents and antibodies used in this study, and synthetic primers used for RT-PCR analysis and mouse genotyping are listed in Key Resourses Table. C57BL mice were used as wild-type mice in this study. Chondrocyte-specific <italic>Trpm7-</italic>knockout mice with C57BL genetic background were generated by crossing <italic>Trpm7</italic><sup>fl/fl</sup> mice (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>) with transgenic mice carrying <italic>Col11a2-Cre</italic>, originally designated as <italic>11Enh-Cre</italic> (<xref ref-type="bibr" rid="bib11">Iwai et al., 2008</xref>) Using primer sets for detecting <italic>Col11a2-Cre</italic> transgene and <italic>Trpm7</italic> alleles, we previously reported that <italic>Trpm7</italic> is specifically inactivated in cartilage tissues from the <italic>Trpm7</italic><sup>flfl</sup>, <italic>Col11a2-Cre</italic><sup>+/−</sup> mice (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>). Chondrocyte-specific <italic>Npr2</italic>-knockout mice with C57BL background were generated as previously described (<xref ref-type="bibr" rid="bib23">Nakao et al., 2015</xref>), and we designed primers for detecting the <italic>Col2a1-Cre</italic> transgene and the floxed <italic>Npr2</italic> gene in this study (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p></sec><sec id="s4-2"><title>Bone slice preparations</title><p>Femoral bones were isolated from E17.5 mice and immersed in a physiological salt solution (PSS): (in mM) 150 NaCl, 4 KCl, 1 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 5.6 glucose, and 5 2-[4-(2-Hydroxyethyl)-1-piperazinyl]ethanesulfonic acid (HEPES, pH 7.4). Longitudinal bone slices (~40 µm thickness) were prepared using a vibrating microslicer (DTK-1000N, Dosaka EM Co., Japan) as previously described (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>).</p></sec><sec id="s4-3"><title>Ca<sup>2+</sup> imaging</title><p>Fura-2 Ca<sup>2+</sup> imaging of bone slices was performed as previously described (<xref ref-type="bibr" rid="bib26">Qian et al., 2019</xref>). Briefly, bone slices placed on glass-bottom dishes (Matsunami, Japan) were incubated in PSS containing 15 μM Fura-2AM for 1 hr at 37°C. Fluorescence microscopy distinguished round, columnar, and hypertrophic chondrocytes with characteristic morphological features in the bone slices loaded with Fura-2. For ratiometric imaging, excitation light of 340 and 380 nm was alternately delivered, and emission light of &gt;510 nm was detected by a cooled EM-CCD camera (Model C9100-13; Hamamatsu Photonics, Japan) mounted on an upright fluorescence microscope (DM6 FS, Leica) using a ×40 water-immersion objective (HCX APO L, Leica). In typical measurements, ~30 round chondrocytes were randomly examined in each slice preparation to select the Ca<sup>2+</sup> fluctuation-positive cells generating spontaneous events (&gt;0.025 in Fura-2 ratio) using commercial software (Leica Application Suite X), and recording traces from the positive cells were then analyzed using Fiji/ImageJ software (US. NIH) for examining Ca<sup>2+</sup> fluctuation amplitude and frequency. Imaging experiments were performed at room temperature (23–25°C) and PSS was used as the normal bathing solution. For the pretreatments of CNP, ANP, and 8-pCPT-cGMP, bone slices were immersed in PSS with the indicated compound for 1 hr at room temperature after Fura-2 loading.</p></sec><sec id="s4-4"><title>Membrane potential monitoring</title><p>Bone slices were perfused with the PSS containing 200 nM oxonol VI at room temperature and analyzed as previously described (<xref ref-type="bibr" rid="bib36">Yamazaki et al., 2011</xref>). To prepare the calibration plot showing the relationship between the fluorescence intensity and membrane potential, saline solutions containing 20, 40, 60, or 100 mM KCl were used as bathing solutions. Fluorescence images with excitation at 559 nm and emission at &gt;606 nm were captured at a sampling rate of ~7.0 s using a confocal laser scanning microscope (FV1000; Olympus).</p></sec><sec id="s4-5"><title>Immunochemical analysis of CaMKII</title><p>Bone slices were pretreated with or without CNP were subjected to immunochemical assessments as previously described (<xref ref-type="bibr" rid="bib16">Li et al., 2011</xref>). Briefly, for immunohistochemical analysis, bone slices were fixed in 4% paraformaldehyde and treated with 1% hyaluronidase to enhance immunodetection (<xref ref-type="bibr" rid="bib1">Ahrens and Dudley, 2011</xref>; <xref ref-type="bibr" rid="bib21">Mouser et al., 2016</xref>). After blocking with fetal bovine serum-containing solution, bone slices were reacted with primary and Alexa 488-conjugated secondary antibodies and observed with a confocal microscope (FV1000; Olympus). For immunoblot analysis, bone slices were lysed in the buffer containing 4% sodium deoxycholate, 20 mM Tris–HCl (pH 8.8) and a phosphatase inhibitor cocktail (100 mM NaF, 10 mM Na<sub>3</sub>PO<sub>4</sub>, 1 mM Na<sub>2</sub>VO<sub>3</sub>, and 20 mM β-glycerophosphate). The resulting lysate proteins were electrophoresed on sodium dodecyl sulfate–polyacrylamide gels and electroblotted onto nylon membranes for immunodetection using primary and Horseradish peroxidase (HRP)-conjugated secondary antibodies. Antigen proteins were visualized using a chemiluminescence reagent and image analyzer (Amersham Imager 600, Cytiva). The immunoreactivities yielded were quantitatively analyzed by means of Fiji/ImageJ software.</p></sec><sec id="s4-6"><title>Metatarsal organ culture</title><p>Metatarsal bone rudiments were cultured as previously described (<xref ref-type="bibr" rid="bib9">Houston et al., 2016</xref>). Briefly, the three central metatarsal rudiments were dissected from E15.5 mice and cultured in αMEM containing 5 μg/ml ascorbic acid, 1 mM β-glycerophosphate pentahydrate, 100 units/ml penicillin, 100 μg/ml streptomycin and 0.2% bovine serum albumin (fatty acid free). The explants were analyzed under a photomicroscope (BZ-X710, Keyence, Japan) for size measurements using Fiji/ImageJ software.</p></sec><sec id="s4-7"><title>Histological analysis</title><p>For histological analysis, cultured bones were fixed in 4% paraformaldehyde, embedded in Super Cryoembedding Medium (Section-lab, Japan), and frozen in liquid nitrogen. Serial cryosections (6 μm in thickness) were prepared from the fixed specimens and stained with hematoxylin and eosin. In the sectional images, round, columnar, and hypertrophic chondrocytes were distinguished by their characteristic morphological features. Microscopic images were quantitatively analyzed using Fiji/ImageJ software.</p></sec><sec id="s4-8"><title>Gene expression analysis</title><p>Quantitative RT-PCR analysis was performed as previously described (<xref ref-type="bibr" rid="bib39">Zhao et al., 2016</xref>). From femoral epiphyses, the terminal region containing round chondrocytes and the adjacent region enriched with columnar and hypertrophic chondrocytes were separated under stereo-microscope. Femoral and humeral speciemens were subjected to total RNA preparation using a commercial reagent (Isogen) for cDNA synthesis using a commercial kit (ReverTra ACE qPCR-RT kit). The resulting cDNAs were examined by real-time PCR (LightCycler 480 II, Roche), and the cycle threshold was determined from the amplification curve as an index for relative mRNA content in each reaction.</p></sec><sec id="s4-9"><title>Quantification and statistical analysis</title><p>All data obtained are presented as the means ± standard error of the mean with <italic>n</italic> values indicating the number of examined mice. Student <italic>t</italic>-test and analysis of variance were used for two-group and multiple group comparisons, respectively (Prism 7, GraphPad Software Inc): p &lt; 0.05 was considered to be statistically significant.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Data curation, Funding acquisition, Investigation, Methodology, Resources</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Data curation, Investigation, Resources</p></fn><fn fn-type="con" id="con11"><p>Investigation, Resources</p></fn><fn fn-type="con" id="con12"><p>Investigation, Resources</p></fn><fn fn-type="con" id="con13"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con14"><p>Data curation, Investigation, Validation</p></fn><fn fn-type="con" id="con15"><p>Resources, Validation</p></fn><fn fn-type="con" id="con16"><p>Resources, Validation</p></fn><fn fn-type="con" id="con17"><p>Conceptualization, Resources, Validation</p></fn><fn fn-type="con" id="con18"><p>Conceptualization, Data curation, Funding acquisition, Investigation, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All experiments in this study were conducted with the approval of the Animal Research Committee according to the regulations on animal experimentation at Kyoto University.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-71931-transrepform1-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1, 2, 3, 4, 5, 6, 7 and 8.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Jun Matsushita (Graduate School of Pharmaceutical Sciences, Kyoto University) for mouse in vitro fertilization. This work was supported in part by the MEXT/JSPS (KAKENHI Grant Number 21H02663, 20H03802, and 21K19565), Platform Project for Supporting Drug Discovery and Life Science Research (JP19am0101092j0003), Takeda Science Foundation, Kobayashi International Scholarship Foundation, the NAKATOMI Foundation, Vehicle Racing Commemorative Foundation, The Mother and Child Health Foundation, and Japan Foundation for Applied Enzymology. Y.M. is grateful for Fujita Jinsei Scholarship from Graduate School of Pharmaceutical Sciences, Kyoto University. F.L. is grateful for Scholarship from Graduate Program for Medical Innovation, Kyoto University, and Otsuka Toshimi Scholarship Foundation.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahrens</surname><given-names>MJ</given-names></name><name><surname>Dudley</surname><given-names>AT</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Chemical pretreatment of growth plate cartilage increases immunofluorescence sensitivity</article-title><source>The Journal of Histochemistry and Cytochemistry</source><volume>59</volume><fpage>408</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1369/0022155411400869</pub-id><pub-id pub-id-type="pmid">21411811</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berendsen</surname><given-names>AD</given-names></name><name><surname>Olsen</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Bone development</article-title><source>Bone</source><volume>80</volume><fpage>14</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2015.04.035</pub-id><pub-id pub-id-type="pmid">26453494</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bibli</surname><given-names>S-I</given-names></name><name><surname>Andreadou</surname><given-names>I</given-names></name><name><surname>Chatzianastasiou</surname><given-names>A</given-names></name><name><surname>Tzimas</surname><given-names>C</given-names></name><name><surname>Sanoudou</surname><given-names>D</given-names></name><name><surname>Kranias</surname><given-names>E</given-names></name><name><surname>Brouckaert</surname><given-names>P</given-names></name><name><surname>Coletta</surname><given-names>C</given-names></name><name><surname>Szabo</surname><given-names>C</given-names></name><name><surname>Kremastinos</surname><given-names>DT</given-names></name><name><surname>Iliodromitis</surname><given-names>EK</given-names></name><name><surname>Papapetropoulos</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway</article-title><source>Cardiovascular Research</source><volume>106</volume><fpage>432</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvv129</pub-id><pub-id pub-id-type="pmid">25870184</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>RB</given-names></name><name><surname>Hatano</surname><given-names>N</given-names></name><name><surname>Kondo</surname><given-names>C</given-names></name><name><surname>Belke</surname><given-names>DD</given-names></name><name><surname>Brown</surname><given-names>BS</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Votta</surname><given-names>BJ</given-names></name><name><surname>Giles</surname><given-names>WR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Voltage-gated K+ currents in mouse articular chondrocytes regulate membrane potential</article-title><source>Channels (Austin, Tex.)</source><volume>4</volume><fpage>179</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.4161/chan.4.3.11629</pub-id><pub-id pub-id-type="pmid">20372061</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>D-L</given-names></name><name><surname>Yue</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>B-F</given-names></name><name><surname>Wang</surname><given-names>W-H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Hydrogen peroxide stimulates the Ca(2+)-activated big-conductance K channels (BK) through cGMP signaling pathway in cultured human endothelial cells</article-title><source>Cellular Physiology and Biochemistry</source><volume>22</volume><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1159/000149789</pub-id><pub-id pub-id-type="pmid">18769038</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fleig</surname><given-names>A</given-names></name><name><surname>Chubanov</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><chapter-title>TRPM7</chapter-title><person-group person-group-type="editor"><name><surname>Fleig</surname><given-names>A</given-names></name></person-group><source>Handbook of Experimental Pharmacology</source><publisher-name>Springer</publisher-name><fpage>521</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1007/978-3-642-54215-2_21</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukao</surname><given-names>M</given-names></name><name><surname>Mason</surname><given-names>HS</given-names></name><name><surname>Britton</surname><given-names>FC</given-names></name><name><surname>Kenyon</surname><given-names>JL</given-names></name><name><surname>Horowitz</surname><given-names>B</given-names></name><name><surname>Keef</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Cyclic GMP-dependent protein kinase activates cloned BKCa channels expressed in mammalian cells by direct phosphorylation at serine 1072</article-title><source>The Journal of Biological Chemistry</source><volume>274</volume><fpage>10927</fpage><lpage>10935</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.16.10927</pub-id><pub-id pub-id-type="pmid">10196172</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>JY</given-names></name><name><surname>Zhang</surname><given-names>MH</given-names></name><name><surname>Jiang</surname><given-names>JZ</given-names></name><name><surname>Piao</surname><given-names>LH</given-names></name><name><surname>Fang</surname><given-names>XS</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Cai</surname><given-names>YL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The role of CNP-mediated PKG/PKA-PLCβ pathway in diabetes-induced gastric motility disorder</article-title><source>Peptides</source><volume>110</volume><fpage>47</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2018.10.012</pub-id><pub-id pub-id-type="pmid">30391424</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houston</surname><given-names>DA</given-names></name><name><surname>Staines</surname><given-names>KA</given-names></name><name><surname>MacRae</surname><given-names>VE</given-names></name><name><surname>Farquharson</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification</article-title><source>Journal of Visualized Experiments</source><volume>1</volume><elocation-id>e54978</elocation-id><pub-id pub-id-type="doi">10.3791/54978</pub-id><pub-id pub-id-type="pmid">28060328</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Mahavadi</surname><given-names>S</given-names></name><name><surname>Sriwai</surname><given-names>W</given-names></name><name><surname>Murthy</surname><given-names>KS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2</article-title><source>American Journal of Physiology. Cell Physiology</source><volume>292</volume><fpage>C200</fpage><lpage>C208</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00103.2006</pub-id><pub-id pub-id-type="pmid">16885398</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwai</surname><given-names>T</given-names></name><name><surname>Murai</surname><given-names>J</given-names></name><name><surname>Yoshikawa</surname><given-names>H</given-names></name><name><surname>Tsumaki</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Smad7 Inhibits chondrocyte differentiation at multiple steps during endochondral bone formation and down-regulates p38 MAPK pathways</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>27154</fpage><lpage>27164</lpage><pub-id pub-id-type="doi">10.1074/jbc.M801175200</pub-id><pub-id pub-id-type="pmid">18644788</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>Y</given-names></name><name><surname>Kugimiya</surname><given-names>F</given-names></name><name><surname>Chikuda</surname><given-names>H</given-names></name><name><surname>Kamekura</surname><given-names>S</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Kawamura</surname><given-names>N</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Shinoda</surname><given-names>Y</given-names></name><name><surname>Higashikawa</surname><given-names>A</given-names></name><name><surname>Yano</surname><given-names>F</given-names></name><name><surname>Ogasawara</surname><given-names>T</given-names></name><name><surname>Ogata</surname><given-names>N</given-names></name><name><surname>Hoshi</surname><given-names>K</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name><name><surname>Woodgett</surname><given-names>JR</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Chung</surname><given-names>U</given-names></name><name><surname>Kawaguchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Phosphorylation of GSK-3beta by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes</article-title><source>The Journal of Clinical Investigation</source><volume>118</volume><fpage>2506</fpage><lpage>2515</lpage><pub-id pub-id-type="doi">10.1172/JCI35243</pub-id><pub-id pub-id-type="pmid">18551195</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krejci</surname><given-names>P</given-names></name><name><surname>Masri</surname><given-names>B</given-names></name><name><surname>Fontaine</surname><given-names>V</given-names></name><name><surname>Mekikian</surname><given-names>PB</given-names></name><name><surname>Weis</surname><given-names>M</given-names></name><name><surname>Prats</surname><given-names>H</given-names></name><name><surname>Wilcox</surname><given-names>WR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis</article-title><source>Journal of Cell Science</source><volume>118</volume><fpage>5089</fpage><lpage>5100</lpage><pub-id pub-id-type="doi">10.1242/jcs.02618</pub-id><pub-id pub-id-type="pmid">16234329</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubacka</surname><given-names>M</given-names></name><name><surname>Kotańska</surname><given-names>M</given-names></name><name><surname>Kazek</surname><given-names>G</given-names></name><name><surname>Waszkielewicz</surname><given-names>AM</given-names></name><name><surname>Marona</surname><given-names>H</given-names></name><name><surname>Filipek</surname><given-names>B</given-names></name><name><surname>Mogilski</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Involvement of the NO/sGC/cGMP/K+ channels pathway in vascular relaxation evoked by two non-quinazoline α<sub>1</sub>-adrenoceptor antagonists</article-title><source>Biomedicine &amp; Pharmacotherapy = Biomedecine &amp; Pharmacotherapie</source><volume>103</volume><fpage>157</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.04.034</pub-id><pub-id pub-id-type="pmid">29653360</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalli</surname><given-names>MJ</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Sutliff</surname><given-names>RL</given-names></name><name><surname>Kranias</surname><given-names>EG</given-names></name><name><surname>Paul</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>[Ca2+]i homeostasis and cyclic nucleotide relaxation in aorta of phospholamban-deficient mice</article-title><source>The American Journal of Physiology</source><volume>277</volume><fpage>H963</fpage><lpage>H970</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.1999.277.3.H963</pub-id><pub-id pub-id-type="pmid">10484417</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Ahrens</surname><given-names>MJ</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Dudley</surname><given-names>AT</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Calcium/calmodulin-dependent protein kinase II activity regulates the proliferative potential of growth plate chondrocytes</article-title><source>Development (Cambridge, England)</source><volume>138</volume><fpage>359</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1242/dev.052324</pub-id><pub-id pub-id-type="pmid">21177348</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Moutton</surname><given-names>S</given-names></name><name><surname>Schrier Vergano</surname><given-names>SA</given-names></name><name><surname>Cogné</surname><given-names>B</given-names></name><name><surname>Saint-Martin</surname><given-names>A</given-names></name><name><surname>Hurst</surname><given-names>ACE</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Bodamer</surname><given-names>O</given-names></name><name><surname>Thevenon</surname><given-names>J</given-names></name><name><surname>Hung</surname><given-names>CY</given-names></name><name><surname>Isidor</surname><given-names>B</given-names></name><name><surname>Gerard</surname><given-names>B</given-names></name><name><surname>Rega</surname><given-names>A</given-names></name><name><surname>Nambot</surname><given-names>S</given-names></name><name><surname>Lehalle</surname><given-names>D</given-names></name><name><surname>Duffourd</surname><given-names>Y</given-names></name><name><surname>Thauvin-Robinet</surname><given-names>C</given-names></name><name><surname>Faivre</surname><given-names>L</given-names></name><name><surname>Bézieau</surname><given-names>S</given-names></name><name><surname>Dure</surname><given-names>LS</given-names></name><name><surname>Helbling</surname><given-names>DC</given-names></name><name><surname>Bick</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Mancini</surname><given-names>GMS</given-names></name><name><surname>Vitobello</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>QK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes</article-title><source>Human Molecular Genetics</source><volume>28</volume><fpage>2937</fpage><lpage>2951</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddz117</pub-id><pub-id pub-id-type="pmid">31152168</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Nishi</surname><given-names>M</given-names></name><name><surname>Ichimura</surname><given-names>A</given-names></name><name><surname>Takeshima</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Enhanced Ca<sup>2+</sup> handling in thioglycolate-elicited peritoneal macrophages</article-title><source>Cell Calcium</source><volume>96</volume><elocation-id>102381</elocation-id><pub-id pub-id-type="doi">10.1016/j.ceca.2021.102381</pub-id><pub-id pub-id-type="pmid">33647639</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martel</surname><given-names>G</given-names></name><name><surname>Hamet</surname><given-names>P</given-names></name><name><surname>Tremblay</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome</article-title><source>Molecular and Cellular Biochemistry</source><volume>334</volume><fpage>53</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1007/s11010-009-0326-8</pub-id><pub-id pub-id-type="pmid">19937369</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazawa</surname><given-names>T</given-names></name><name><surname>Ogawa</surname><given-names>Y</given-names></name><name><surname>Chusho</surname><given-names>H</given-names></name><name><surname>Yasoda</surname><given-names>A</given-names></name><name><surname>Tamura</surname><given-names>N</given-names></name><name><surname>Komatsu</surname><given-names>Y</given-names></name><name><surname>Pfeifer</surname><given-names>A</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name><name><surname>Nakao</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification</article-title><source>Endocrinology</source><volume>143</volume><fpage>3604</fpage><lpage>3610</lpage><pub-id pub-id-type="doi">10.1210/en.2002-220307</pub-id><pub-id pub-id-type="pmid">12193576</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouser</surname><given-names>VHM</given-names></name><name><surname>Melchels</surname><given-names>FPW</given-names></name><name><surname>Visser</surname><given-names>J</given-names></name><name><surname>Dhert</surname><given-names>WJA</given-names></name><name><surname>Gawlitta</surname><given-names>D</given-names></name><name><surname>Malda</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Yield stress determines bioprintability of hydrogels based on gelatin-methacryloyl and gellan gum for cartilage bioprinting</article-title><source>Biofabrication</source><volume>8</volume><elocation-id>035003</elocation-id><pub-id pub-id-type="doi">10.1088/1758-5090/8/3/035003</pub-id><pub-id pub-id-type="pmid">27431733</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakao</surname><given-names>K</given-names></name><name><surname>Itoh</surname><given-names>H</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Mukoyama</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The natriuretic peptide family Curr Opin Nephrol Hypertens</article-title><source>Current Opinion in Nephrology and Hypertension</source><volume>5</volume><fpage>4</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1097/00041552-199601000-00003</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakao</surname><given-names>K</given-names></name><name><surname>Osawa</surname><given-names>K</given-names></name><name><surname>Yasoda</surname><given-names>A</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name><name><surname>Fujii</surname><given-names>T</given-names></name><name><surname>Kondo</surname><given-names>E</given-names></name><name><surname>Koyama</surname><given-names>N</given-names></name><name><surname>Kanamoto</surname><given-names>N</given-names></name><name><surname>Miura</surname><given-names>M</given-names></name><name><surname>Kuwahara</surname><given-names>K</given-names></name><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Bessho</surname><given-names>K</given-names></name><name><surname>Nakao</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>10554</elocation-id><pub-id pub-id-type="doi">10.1038/srep10554</pub-id><pub-id pub-id-type="pmid">26014585</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalli</surname><given-names>AD</given-names></name><name><surname>Kumar</surname><given-names>DP</given-names></name><name><surname>Al-Shboul</surname><given-names>O</given-names></name><name><surname>Mahavadi</surname><given-names>S</given-names></name><name><surname>Kuemmerle</surname><given-names>JF</given-names></name><name><surname>Grider</surname><given-names>JR</given-names></name><name><surname>Murthy</surname><given-names>KS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Regulation of Gβγi-dependent PLC-β3 activity in smooth muscle: inhibitory phosphorylation of PLC-β3 by PKA and PKG and stimulatory phosphorylation of Gαi-GTPase-activating protein RGS2 by PKG</article-title><source>Cell Biochemistry and Biophysics</source><volume>70</volume><fpage>867</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1007/s12013-014-9992-6</pub-id><pub-id pub-id-type="pmid">24777815</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peake</surname><given-names>NJ</given-names></name><name><surname>Hobbs</surname><given-names>AJ</given-names></name><name><surname>Pingguan-Murphy</surname><given-names>B</given-names></name><name><surname>Salter</surname><given-names>DM</given-names></name><name><surname>Berenbaum</surname><given-names>F</given-names></name><name><surname>Chowdhury</surname><given-names>TT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of C-type natriuretic peptide signalling in maintaining cartilage and bone function</article-title><source>Osteoarthritis and Cartilage</source><volume>22</volume><fpage>1800</fpage><lpage>1807</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2014.07.018</pub-id><pub-id pub-id-type="pmid">25086404</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>N</given-names></name><name><surname>Ichimura</surname><given-names>A</given-names></name><name><surname>Takei</surname><given-names>D</given-names></name><name><surname>Sakaguchi</surname><given-names>R</given-names></name><name><surname>Kitani</surname><given-names>A</given-names></name><name><surname>Nagaoka</surname><given-names>R</given-names></name><name><surname>Tomizawa</surname><given-names>M</given-names></name><name><surname>Miyazaki</surname><given-names>Y</given-names></name><name><surname>Miyachi</surname><given-names>H</given-names></name><name><surname>Numata</surname><given-names>T</given-names></name><name><surname>Kakizawa</surname><given-names>S</given-names></name><name><surname>Nishi</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Takeshima</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TRPM7 channels mediate spontaneous Ca<sup>2+</sup> fluctuations in growth plate chondrocytes that promote bone development</article-title><source>Science Signaling</source><volume>12</volume><elocation-id>eaaw4847</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aaw4847</pub-id><pub-id pub-id-type="pmid">30967513</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raeymaekers</surname><given-names>L</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name><name><surname>Casteels</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle</article-title><source>The Biochemical Journal</source><volume>252</volume><fpage>269</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1042/bj2520269</pub-id><pub-id pub-id-type="pmid">2844148</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savarirayan</surname><given-names>R</given-names></name><name><surname>Tofts</surname><given-names>L</given-names></name><name><surname>Irving</surname><given-names>M</given-names></name><name><surname>Wilcox</surname><given-names>W</given-names></name><name><surname>Bacino</surname><given-names>CA</given-names></name><name><surname>Hoover-Fong</surname><given-names>J</given-names></name><name><surname>Ullot Font</surname><given-names>R</given-names></name><name><surname>Harmatz</surname><given-names>P</given-names></name><name><surname>Rutsch</surname><given-names>F</given-names></name><name><surname>Bober</surname><given-names>MB</given-names></name><name><surname>Polgreen</surname><given-names>LE</given-names></name><name><surname>Ginebreda</surname><given-names>I</given-names></name><name><surname>Mohnike</surname><given-names>K</given-names></name><name><surname>Charrow</surname><given-names>J</given-names></name><name><surname>Hoernschemeyer</surname><given-names>D</given-names></name><name><surname>Ozono</surname><given-names>K</given-names></name><name><surname>Alanay</surname><given-names>Y</given-names></name><name><surname>Arundel</surname><given-names>P</given-names></name><name><surname>Kagami</surname><given-names>S</given-names></name><name><surname>Yasui</surname><given-names>N</given-names></name><name><surname>White</surname><given-names>KK</given-names></name><name><surname>Saal</surname><given-names>HM</given-names></name><name><surname>Leiva-Gea</surname><given-names>A</given-names></name><name><surname>Luna-González</surname><given-names>F</given-names></name><name><surname>Mochizuki</surname><given-names>H</given-names></name><name><surname>Basel</surname><given-names>D</given-names></name><name><surname>Porco</surname><given-names>DM</given-names></name><name><surname>Jayaram</surname><given-names>K</given-names></name><name><surname>Fisheleva</surname><given-names>E</given-names></name><name><surname>Huntsman-Labed</surname><given-names>A</given-names></name><name><surname>Day</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial</article-title><source>Lancet (London, England)</source><volume>396</volume><fpage>684</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31541-5</pub-id><pub-id pub-id-type="pmid">32891212</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Yasoda</surname><given-names>A</given-names></name><name><surname>Yamashita</surname><given-names>Y</given-names></name><name><surname>Kanai</surname><given-names>Y</given-names></name><name><surname>Hirota</surname><given-names>K</given-names></name><name><surname>Yamauchi</surname><given-names>I</given-names></name><name><surname>Kondo</surname><given-names>E</given-names></name><name><surname>Sakane</surname><given-names>Y</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name><name><surname>Nakao</surname><given-names>K</given-names></name><name><surname>Fujii</surname><given-names>T</given-names></name><name><surname>Inagaki</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C-type natriuretic peptide restores impaired skeletal growth in a murine model of glucocorticoid-induced growth retardation</article-title><source>Bone</source><volume>92</volume><fpage>157</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2016.08.026</pub-id><pub-id pub-id-type="pmid">27594049</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasques</surname><given-names>GA</given-names></name><name><surname>Arnhold</surname><given-names>IJP</given-names></name><name><surname>Jorge</surname><given-names>AAL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of the natriuretic peptide system in normal growth and growth disorders</article-title><source>Hormone Research in Paediatrics</source><volume>82</volume><fpage>222</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1159/000365049</pub-id><pub-id pub-id-type="pmid">25196103</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>RE</given-names></name><name><surname>Kryman</surname><given-names>JP</given-names></name><name><surname>El-Mowafy</surname><given-names>AM</given-names></name><name><surname>Han</surname><given-names>G</given-names></name><name><surname>Carrier</surname><given-names>GO</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>cAMP-dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate BK(Ca) channel activity in coronary artery smooth muscle cells</article-title><source>Circulation Research</source><volume>86</volume><fpage>897</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1161/01.res.86.8.897</pub-id><pub-id pub-id-type="pmid">10785513</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wit</surname><given-names>JM</given-names></name><name><surname>Camacho-Hübner</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Endocrine regulation of longitudinal bone growth</article-title><source>Endocrine Development</source><volume>21</volume><fpage>30</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1159/000328119</pub-id><pub-id pub-id-type="pmid">21865752</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wit</surname><given-names>JM</given-names></name><name><surname>Oostdijk</surname><given-names>W</given-names></name><name><surname>Losekoot</surname><given-names>M</given-names></name><name><surname>van Duyvenvoorde</surname><given-names>HA</given-names></name><name><surname>Ruivenkamp</surname><given-names>CAL</given-names></name><name><surname>Kant</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MECHANISMS IN ENDOCRINOLOGY: Novel genetic causes of short stature</article-title><source>European Journal of Endocrinology</source><volume>174</volume><fpage>R145</fpage><lpage>R173</lpage><pub-id pub-id-type="doi">10.1530/EJE-15-0937</pub-id><pub-id pub-id-type="pmid">26578640</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>C</given-names></name><name><surname>Bao</surname><given-names>Z</given-names></name><name><surname>Yue</surname><given-names>C</given-names></name><name><surname>Sanborn</surname><given-names>BM</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Phosphorylation and regulation of G-protein-activated phospholipase C-beta 3 by cGMP-dependent protein kinases</article-title><source>The Journal of Biological Chemistry</source><volume>276</volume><fpage>19770</fpage><lpage>19777</lpage><pub-id pub-id-type="doi">10.1074/jbc.M006266200</pub-id><pub-id pub-id-type="pmid">11278298</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Fujii</surname><given-names>T</given-names></name><name><surname>Yamauchi</surname><given-names>I</given-names></name><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Hirota</surname><given-names>K</given-names></name><name><surname>Kanai</surname><given-names>Y</given-names></name><name><surname>Yasoda</surname><given-names>A</given-names></name><name><surname>Inagaki</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>C-Type Natriuretic Peptide Restores Growth Impairment Under Enzyme Replacement in Mice With Mucopolysaccharidosis VII</article-title><source>Endocrinology</source><volume>161</volume><elocation-id>bqaa008</elocation-id><pub-id pub-id-type="doi">10.1210/endocr/bqaa008</pub-id><pub-id pub-id-type="pmid">31974587</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>D</given-names></name><name><surname>Tabara</surname><given-names>Y</given-names></name><name><surname>Kita</surname><given-names>S</given-names></name><name><surname>Hanada</surname><given-names>H</given-names></name><name><surname>Komazaki</surname><given-names>S</given-names></name><name><surname>Naitou</surname><given-names>D</given-names></name><name><surname>Mishima</surname><given-names>A</given-names></name><name><surname>Nishi</surname><given-names>M</given-names></name><name><surname>Yamamura</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Kakizawa</surname><given-names>S</given-names></name><name><surname>Miyachi</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Miyata</surname><given-names>T</given-names></name><name><surname>Kawano</surname><given-names>Y</given-names></name><name><surname>Kamide</surname><given-names>K</given-names></name><name><surname>Ogihara</surname><given-names>T</given-names></name><name><surname>Hata</surname><given-names>A</given-names></name><name><surname>Umemura</surname><given-names>S</given-names></name><name><surname>Soma</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Imaizumi</surname><given-names>Y</given-names></name><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Iwamoto</surname><given-names>T</given-names></name><name><surname>Takeshima</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>TRIC-A channels in vascular smooth muscle contribute to blood pressure maintenance</article-title><source>Cell Metabolism</source><volume>14</volume><fpage>231</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.05.011</pub-id><pub-id pub-id-type="pmid">21803293</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasoda</surname><given-names>A.</given-names></name><name><surname>Ogawa</surname><given-names>Y</given-names></name><name><surname>Suda</surname><given-names>M</given-names></name><name><surname>Tamura</surname><given-names>N</given-names></name><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Sakuma</surname><given-names>Y</given-names></name><name><surname>Chusho</surname><given-names>H</given-names></name><name><surname>Shiota</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Nakao</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Natriuretic Peptide Regulation of Endochondral Ossification</article-title><source>Journal of Biological Chemistry</source><volume>273</volume><fpage>11695</fpage><lpage>11700</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.19.11695</pub-id><pub-id pub-id-type="pmid">9565590</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasoda</surname><given-names>A</given-names></name><name><surname>Komatsu</surname><given-names>Y</given-names></name><name><surname>Chusho</surname><given-names>H</given-names></name><name><surname>Miyazawa</surname><given-names>T</given-names></name><name><surname>Ozasa</surname><given-names>A</given-names></name><name><surname>Miura</surname><given-names>M</given-names></name><name><surname>Kurihara</surname><given-names>T</given-names></name><name><surname>Rogi</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Suda</surname><given-names>M</given-names></name><name><surname>Tamura</surname><given-names>N</given-names></name><name><surname>Ogawa</surname><given-names>Y</given-names></name><name><surname>Nakao</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway</article-title><source>Nature Medicine</source><volume>10</volume><fpage>80</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1038/nm971</pub-id><pub-id pub-id-type="pmid">14702637</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Ichimura</surname><given-names>A</given-names></name><name><surname>Qian</surname><given-names>N</given-names></name><name><surname>Iida</surname><given-names>T</given-names></name><name><surname>Yamazaki</surname><given-names>D</given-names></name><name><surname>Noma</surname><given-names>N</given-names></name><name><surname>Asagiri</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Komazaki</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>C</given-names></name><name><surname>Aoyama</surname><given-names>F</given-names></name><name><surname>Sawaguchi</surname><given-names>A</given-names></name><name><surname>Kakizawa</surname><given-names>S</given-names></name><name><surname>Nishi</surname><given-names>M</given-names></name><name><surname>Takeshima</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mice lacking the intracellular cation channel TRIC-B have compromised collagen production and impaired bone mineralization</article-title><source>Science Signaling</source><volume>9</volume><elocation-id>ra49</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aad9055</pub-id><pub-id pub-id-type="pmid">27188440</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zois</surname><given-names>NE</given-names></name><name><surname>Bartels</surname><given-names>ED</given-names></name><name><surname>Hunter</surname><given-names>I</given-names></name><name><surname>Kousholt</surname><given-names>BS</given-names></name><name><surname>Olsen</surname><given-names>LH</given-names></name><name><surname>Goetze</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Natriuretic peptides in cardiometabolic regulation and disease</article-title><source>Nature Reviews. Cardiology</source><volume>11</volume><fpage>403</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2014.64</pub-id><pub-id pub-id-type="pmid">24820868</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71931.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Safadi</surname><given-names>Fayez</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04q9qf557</institution-id><institution>Northeast Ohio Medical University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.09.17.460760" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.09.17.460760"/></front-stub><body><p>With the new additional data and descriptions, the paper in its current state is well organized and data presented add a new information on the role of C-type natriuretic peptide and how it facilitates autonomic Ca<sup>2+</sup> entry in chondrocytes and modulates bone growth.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71931.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Safadi</surname><given-names>Fayez</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04q9qf557</institution-id><institution>Northeast Ohio Medical University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Safadi</surname><given-names>Fayez</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04q9qf557</institution-id><institution>Northeast Ohio Medical University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Khan</surname><given-names>Nazir M</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03czfpz43</institution-id><institution>Emory University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.09.17.460760">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.09.17.460760v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;C-type natriuretic peptide facilitates autonomic ca<sup>2+</sup> entry in growth plate chondrocytes for stimulating bone growth&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, including Fayez Safadi as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Mone Zaidi as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Nazir M Khan (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) The authors needs to clarify the definition of &quot;round&quot; chondrocytes. Does this mean differentiating/hypertrophic chondrocytes. If this is the case, then I would replace the term&quot;round&quot; by differentiating or hypertrophic chondrocytes.</p><p>2) It would be helpful in the authors include a definitive evidence on the state of the chondrocytes assessed in the study. On other word, please provide a staining or expression of markers for chondrocytes differentiated state, e.g. Sox-9, Collagen X, expression.</p><p>3) Data presented on ex vivo bone growth would be strongly supported if histological images are provided (staining of H/E) to define at what stage of chondrocyte differentiation is pharmacological treatment alters chondrocytes differentiation and function.</p><p>4) It would be very helpful in the authors corellate the role of C-type natriuretic peptide in endothelial cells and bone growth and how the role C-type natriuretic peptide might contribute to endochondral ossification.</p><p>5) Does the role of C-type natriuretic peptide regulate intramembranous bone formation, i.e. does C-type natriuretic peptide regulate osteoblast differentiation/function at a similar fashion as chondrocytes. Please discuss this in the &quot;Discussion section&quot;</p><p>6) How does Trpm7 modulate the CNP mediated bone growth? What effect Trpm7 have on on osteogenesis or osteoclastogenesis?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71931.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The authors needs to clarify the definition of &quot;round&quot; chondrocytes. Does this mean differentiating/hypertrophic chondrocytes. If this is the case, then I would replace the term&quot;round&quot; by differentiating or hypertrophic chondrocytes.</p></disp-quote><p>As described in many original and review articles [for example, 1, 2], growth plate chondrocytes are morphologically classified into three distinct types; round, columnar, and hypertrophic chondrocytes. We followed the established nomenclature, and “round chondrocyte” is a common word in developmental bone biology. As shown in our previous report, fluorescence microscopic observations can clearly distinguish round, columnar, and hypertrophic chondrocytes in longitudinal bone slices loaded with the ca<sup>2+</sup> indicators (Qian N., et al., <italic>Sci Signal.</italic>, 12:eaaw4847, 2019). By using the slice preparations, we have previously demonstrated that both round and columnar chondrocytes generate spontaneous TRPM7-mediated ca<sup>2+</sup> fluctuations that promote self-maturation and growth plate development [3]. We have briefly explained cells assessed in the Method section of the revised manuscript (line 309-311 and line 361-364).</p><disp-quote content-type="editor-comment"><p>2) It would be helpful in the authors include a definitive evidence on the state of the chondrocytes assessed in the study. On other word, please provide a staining or expression of markers for chondrocytes differentiated state, e.g. Sox-9, Collagen X, expression.</p></disp-quote><p>In response to the comment, we examined the expression of several chondrocyte marker genes, including <italic>Sox9</italic>, <italic>Col10a1</italic> and <italic>Runx2</italic>. Previous studies [4-6] indicate that <italic>Col10a1</italic> is exclusively expressed in hypertrophic chondrocytes, whereas <italic>Sox9</italic> expression is mainly observed in both round and columnar chondrocytes. We isolated the terminal region containing round chondrocytes and the adjacent region that is enriched with columnar and hypertrophic chondrocytes from femoral epiphyses. Both the preparations were subjected to total RNA preparations for quantitative real-time PCR analysis. In consistent with the previous reports, <italic>Col10a1</italic> expression was densely observed in the columnar and hypertrophic preparations, whereas <italic>Sox9</italic> expression was similar between both the preparations (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>). The new data obtained are now included in Figure 1—figure supplement 2 in the revised manuscript.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Total RNAs were prepared from growth plate sections packed with round chondrocytes or enriched with columnar and hypertrophic chondrocytes from wild-type mice and subjected to quantitative RT-PCR analysis.</title><p>The data represent the mean ± SEM, and the numbers of mice examined are shown in parentheses. Significant differences between the growth plate sections are marked with asterisks (*<italic>p</italic>&lt;0.05 and **<italic>p</italic>&lt;0.01 in <italic>t</italic>-test).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-sa2-fig1-v1.tif"/></fig><p>We also analyzed <italic>Col10a1</italic> and <italic>Sox9</italic> expression in chondrocyte-specific <italic>Npr2</italic>-knockout humeral bones. The clarified profiles for the marker genes were largely similar between chondrocyte-specific <italic>Npr2</italic>-knockout and control bones, suggesting that the <italic>Npr2</italic> deficiency does not affect fundamental chondrocytic differentiation in growth plates. The new data obtained are now included in Figure 1—figure supplement 1D in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3) Data presented on ex vivo bone growth would be strongly supported if histological images are provided (staining of H/E) to define at what stage of chondrocyte differentiation is pharmacological treatment alters chondrocytes differentiation and function.</p></disp-quote><p>In response to the comment, we histologically analyzed cultured CNP-treated bones from the chondrocyte-specific <italic>Trpm7</italic>-knockout (<italic>Trpm7</italic><sup>fl/fl</sup>, <italic>11Enh-Cre</italic><sup>+/−</sup>) and control (<italic>Trpm7</italic><sup>fl/fl</sup>, <italic>11Enh-Cre</italic><sup>−/−</sup>) mice. The new data obtained clearly indicate that CNP treatments extend the columnar chondrocytic zones in control bones but not in chondrocyte-specific <italic>Trpm7</italic>-knockout bones (Figure 7 in the revised manuscript). We further analyzed in detail CNP-treated metatarsal bones from wild-type mice. CNP-treatments consistently expanded the columnar chondrocytic zones but did not affect the cell densities (Figure 7—figure supplement 1 in the revised manuscript). The expansion seemed to be mainly caused by enlarged extracellular matrix area, although CNP significantly dilated the cell size in columnar and hypertrophic chondrocytes. The observations suggest that CNP promotes cell growth and extracellular matrix production but has no obvious effects on cell proliferation. These results are described in the Results and Discussion sections of the revised manuscript (line 211-214, line 219-220 and line 255-262).</p><disp-quote content-type="editor-comment"><p>4) It would be very helpful in the authors corellate the role of C-type natriuretic peptide in endothelial cells and bone growth and how the role C-type natriuretic peptide might contribute to endochondral ossification.</p></disp-quote><p>Accumulating evidence so-far indicates that CNP functions as autocrine and paracrine factors in several tissues, and is a paracrine vasodilator in blood vessels [7]. Indeed, endothelium-specific <italic>Nppc-</italic>knockout mice exhibit elevated blood pressure due to the deficiency of CNP-induced vasodilation signaling (<italic>Nppc</italic>, the gene symbol of CNP). However, endothelium-specific <italic>Nppc</italic>-knockout mice maintain normal skeletal development [8], indicating that CNP derived from endothelial cells does not correlate with bone growth.</p><p>As in our reply to the comment (3), CNP-induced effects became clear in growth plates. To further analyze the effects of CNP on osteoblasts and osteoclasts in developing bones, we performed histochemical analysis as described below (see our reply to the comment 5).</p><disp-quote content-type="editor-comment"><p>5) Does the role of C-type natriuretic peptide regulate intramembranous bone formation, i.e. does C-type natriuretic peptide regulate osteoblast differentiation/function at a similar fashion as chondrocytes. Please discuss this in the &quot;Discussion section&quot;</p></disp-quote><p>In our Kossa-staining analysis of chondrocyte-specific <italic>Npr2</italic>-knockout (<italic>Npr2</italic><sup>fl/fl</sup>, <italic>Col2a1-Cre</italic><sup>+/−</sup>) and control (<italic>Npr2</italic><sup>fl/fl</sup>, <italic>Col2a1-Cre</italic><sup>−/−</sup>) mice, femoral bones from the E17.5 knockout mice exhibited insufficient mineralization (<xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>). In the chondrocyte-specific <italic>Npr2</italic>-knockout bones, the impaired ossification may be indirectly caused by impaired growth plate development. Alternatively, it might be possible that the poor mineralization underlies hyperactivation of osteoclasts and/or hypoactivation of osteoblasts due to non-specific expression of Cre recombinase in the chondrocyte-specific <italic>Npr2</italic>-knockout bones. Although NPR2 expression has not been reported in osteoclasts and osteoblasts, a recent study implies that CNP may directly stimulate osteogenic differentiation in primary cultured osteoblast progenitors [9]. On the other hand, previous in vivo study using <italic>Nppc</italic>-knockout and transgenic mice demonstrates that CNP generally induces the overgrowth of long-bones formed through endochondral ossification, but that CNP does not affect skull bone formed through intramembranous ossification [10], suggesting that CNP has no effect on osteoblastgenesis. Therefore, CNP-induced effects on osteoblasts and osteoclasts have not yet been clarified.</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>Impaired bone mineralization in the chondrocyte-specific <italic>Npr2</italic>-knockout embryos.</title><p>Kossa-stained mid-cross sections of femoral bones from the chondrocyte-specific <italic>Npr2</italic>-knockout (<italic>Npr2</italic><sup>fl/fl</sup><italic>, Col2a1-Cre</italic><sup>+/-</sup>) and control (<italic>Npr2</italic><sup>fl/fl</sup><italic>, Col2a1-Cre</italic><sup>-/-</sup>) E17.5 embryos. Scale bar, 0.3 mm. Both the cross-sectional area and Kossa-positive area were determined from digitalized images, and the Kossa-positive fraction in the cross-sectional area (Kossa-stained ratio) was calculated (graphs). <italic>n</italic> values represent the numbers of mice examined and are shown in parentheses. Significant differences between the groups are marked with asterisks (*<italic>p</italic>&lt; 0.05, **<italic>p</italic>&lt;0.01 in <italic>t</italic>-test).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-sa2-fig2-v1.tif"/></fig><p>In our previous study, we examined primary cultured osteoblasts and osteoclasts in ca<sup>2+</sup> imaging, but could not detect spontaneous ca<sup>2+</sup> fluctuations [11]. Therefore, it is unlikely that the CNP-NPR2-BK channel-TRPM7 channel axis is functioning in both the cell types. To clarify CNP-induced effects on osteoblasts and osteoclasts, it is needed to produce specific model animals; for example, osteoblast-specific <italic>Npr2</italic>-knockout mice using the <italic>Col1a1-Cre</italic> transgene and osteoclast-specific <italic>Npr2</italic>-knockout mice using the <italic>Lyz2-Cre</italic> transgene. Although we are willing to analyze CNP effects on osteoblast/clast in the future project, we cannot unfortunately make meaningful discussion on osteoblasts at the present and regret so much about it.</p><disp-quote content-type="editor-comment"><p>6) How does Trpm7 modulate the CNP mediated bone growth? What effect Trpm7 have on on osteogenesis or osteoclastogenesis?</p></disp-quote><p>We previously reported that TRPM7 channels mediate intermissive ca<sup>2+</sup> influx in both round and columnar chondrocytes, leading to activation of ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) for promoting bone outgrowth [3]. Our preset study demonstrates that CNP-facilitated bone outgrowth essentially requires the activation of TRPM7-mediated ca<sup>2+</sup> influx. In response to the comment, we analyzed femoral bones from chondrocyte-specific <italic>Trpm7</italic>-knockout mice by conventional activity staining for alkaline phosphatase (ALP, osteoblast marker) and tartrate-resistant acid phosphatase (TRAP, osteoclast maker). The mutant and control bones exhibited similar regional ALP and TRAP-staining densities and distributions (<xref ref-type="fig" rid="sa2fig3">Author response image 3</xref>). Although <italic>Trpm7</italic> expression and function are unknown in osteoblasts and osteoclasts at the present, <italic>Trpm7</italic> expression in growth plate chondrocytes seems to have no obvious effects on osteoblastgenesis and osteoclastogenesis.</p><fig id="sa2fig3" position="float"><label>Author response image 3.</label><caption><title>Histological analysis in femoral bone of chondrocyte-specific <italic>Trpm7</italic>-knockout mice.</title><p>Histological analysis of osteoblasts (ALP staining, A) and osteoclasts (TRAP staining, B) in longitudinal sections of femurs from the chondrocyte-specific <italic>Trpm7</italic>-knockout (<italic>Trpm7</italic><sup>fl/fl</sup><italic>, 11Enh-Cre</italic><sup>+/-</sup>) and control (<italic>Trpm7</italic><sup>fl/fl</sup><italic>, 11Enh-Cre</italic><sup>-/-</sup>) E15.5 embryos. Higher-magnification views are also shown in the lower panels. Scale bar, 0.3 mm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71931-sa2-fig3-v1.tif"/></fig><p>References</p><p>1. Hallett, S.A., Ono, W., and Ono, N. (2019). Growth Plate Chondrocytes: Skeletal Development, Growth and Beyond. International Journal of Molecular Sciences <italic>20</italic>, 6009.</p><p>2. Jochmann, K., Bachvarova, V., and Vortkamp, A. (2014). Heparan sulfate as a regulator of endochondral ossification and osteochondroma development. Matrix Biology <italic>34</italic>, 55-63.</p><p>3. Qian, N., Ichimura, A., Takei, D., Sakaguchi, R., Kitani, A., Nagaoka, R., Tomizawa, M., Miyazaki, Y., Miyachi, H., Numata, T., et al. (2019). TRPM7 channels mediate spontaneous ca<sup>2+</sup> fluctuations in growth plate chondrocytes that promote bone development Sci Signal. <italic>12</italic>, eaaw4847.</p><p>4. Hino, K., Saito, A., Kido, M., Kanemoto, S., Asada, R., Takai, T., Cui, M., Cui, X., and Imaizumi, K. (2014). Master Regulator for Chondrogenesis, <italic>Sox9</italic>, Regulates Transcriptional Activation of the Endoplasmic Reticulum Stress Transducer BBF2H7/CREB3L2 in Chondrocytes. Journal of Biological Chemistry <italic>289</italic>, 13810-13820.</p><p>5. Kato, K., Bhattaram, P., Penzo‐Méndez, A., Gadi, A., and Lefebvre, V. (2015). SOXC Transcription Factors Induce Cartilage Growth Plate Formation in Mouse Embryos by Promoting Noncanonical WNT Signaling. Journal of Bone and Mineral Research <italic>30</italic>, 1560-1571.</p><p>6. Leung, V.Y.L., Gao, B., Leung, K.K.H., Melhado, I.G., Wynn, S.L., Au, T.Y.K., Dung, N.W.F., Lau, J.Y.B., Mak, A.C.Y., Chan, D., et al. (2011). <italic>SOX9</italic> Governs Differentiation Stage-Specific Gene Expression in Growth Plate Chondrocytes via Direct Concomitant Transactivation and Repression. PLoS Genetics <italic>7</italic>, e1002356.</p><p>7. Moyes, A.J., and Hobbs, A.J. (2019). C-Type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature. International Journal of Molecular Sciences <italic>20</italic>, 2281.</p><p>8. Nakao, K., Kuwahara, K., Nishikimi, T., Nakagawa, Y., Kinoshita, H., Minami, T., Kuwabara, Y., Yamada, C., Yamada, Y., Tokudome, T., et al. (2017). Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity. Hypertension <italic>69</italic>, 286-296.</p><p>9. Watanabe-Takano, H., Ochi, H., Chiba, A., Matsuo, A., Kanai, Y., Fukuhara, S., Ito, N., Sako, K., Miyazaki, T., Tainaka, K., et al. (2021). Mechanical load regulates bone growth via periosteal Osteocrin. Cell Reports <italic>36</italic>, 109380.</p><p>10. Nakao, K., Okubo, Y., Yasoda, A., Koyama, N., Osawa, K., Isobe, Y., Kondo, E., Fujii, T., Miura, M., Nakao, K., et al. (2012). The Effects of C-type Natriuretic Peptide on Craniofacial Skeletogenesis. Journal of Dental Research <italic>92</italic>, 58-64.</p><p>11. Chengzhu, Z., Ichimura, A., Qian, N., Iida, T., Yamazaki, D., Noma, N., Asagiri, M., Yamamoto, K., Komazaki, S., Sato, C., et al. (2016). Mice lacking the intracellular cation channel TRIC-B have compromised collagen production and impaired bone mineralization. Sci Signal. <italic>9</italic>, ra49.</p></body></sub-article></article>